Nanoparticle-Coated Poly(3-Hydroxybutyrate) Granules For Biomedical Applications by Rey, Diego
  
NANOPARTICLE-COATED POLY(3-HYDROXYBUTYRATE) GRANULES FOR 
BIOMEDICAL APPLICATIONS 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
by 
Diego Rey 
                                               August 2012 
 
  
 
 
 
 
 
 
 
 
© 2012 Diego Rey
  
NANOPARTICLE-COATED POLY(3-HYDROXYBUTYRATE) GRANULES FOR 
BIOMEDICAL APPLICATIONS 
 
Diego Rey, Ph. D. 
Cornell University 2012 
 
Poly(3-hydroxybutyrate) (PHB) is a biodegradable and biocompatible polymer 
produced by many bacteria as a stored carbon source.  Recent reviews have recently 
recognized PHB granules as a biomaterial that can be functionalized for use in various 
biomedical applications.  The studies in this dissertation describe a novel means of 
producing nanoparticle-coated PHB granules that expands the capabilities of 
functionalized PHB granules through harnessing versatile properties of inorganic 
nanoparticles. 
PHA synthase was conjugated to gold nanoparticles (AuNP) and 
superparamagnetic iron oxide nanoparticles (SPION) and upon the addition of 3-
hydroxybutyrate-CoA (3HB-CoA), these nanoparticle-PHA synthase conjugates 
produce poly(3-hydroxybutyrate) (PHB) which aggregate to form nano- to micron-
sized nanoparticle-coated PHB granules.  The resulting nanoparticle-polymer hybrid-
materials are shown to exhibit unique properties to those of PHB and the nanoparticles 
alone and are a result of the rearrangement of the nanoparticles on the PHB granule 
surface. 
SPION-coated PHB granules are potential enhanced MRI contrast agents 
exhibiting ~2-fold improvement in spin-spin (T2) relaxivity (168 s-1 mmol-1 Fe) when 
compared to free SPION conjugated to PHA synthase (87.5 s-1 mmol-1 Fe).  Control of 
the SPION-coated PHB granule size is also demonstrated via the addition of the 
 surfactant Tween 20 that allows for producing PHB granules as small as 100 nm in 
diameter offering the possibility of controlling their biodistribution.  Furthermore, 
SPION-PHA synthase is shown to also allow for controlled retention of SPION within 
porous matrices via PHB polymerization where in situ polymerization of PHB from 
SPION-PHA synthase within agarose gel was shown retain up to 4.2-times greater 
amount of SPION when compared to SPION-PHA synthase samples that did not 
undergo polymerization. 
Similarly, gold nanoparticle-coated PHB granules also exhibit unique 
properties that may be suitable in biomedical applications.  AuNP-coated PHB 
granules are potential theranostic agents that have enhanced imaging capabilities, 
including surface-enhanced Raman scattering (SERS) and enhanced fluorescence, and 
can generate localized heating upon near-infrared (NIR) laser irradiation.  The AuNP-
coated PHB exhibited 11-fold enhancement in SERS over AuNP-PHA synthase 
particles prior polymerization.  In addition, AuNP-coated PHB stained with the 
fluorophore Nile red exhibited a 6-fold enhancement in fluorescence intensity as well 
as a 1.3-fold decrease in photobleaching rate when compared to PHB granules alone.  
The granules were also shown to emit heat when illuminated at 808 nm with a 3.9-fold 
increase in heating rate when compared to AuNP-PHA synthase alone.  In addition, 
NIR laser illumination of fluorescent doxorubicin (Dox)-loaded AuNP-PHB granules 
resulted in loss of fluorescence due to destruction of the PHB granule structure, 
providing a potential means of laser-triggered drug delivery from AuNP-PHB 
granules.
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Chapter 1 – Background  
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1.1.  Polyhydroxyalkanoates 
Polyhydroxyalkanoates (PHAs) are polyesters that are synthesized from (R)-3-
hydroxyacyl-CoA by many bacteria(1-6) under conditions of limited nutrients and 
excess carbon(7-10) for conditions of carbon starvation(11, 12) (Figure 1.1).  The 
primary enzymes involved in PHA synthesis are PHA synthases accompanied by 
several granule associated proteins (GAPs) which are designated to four classes: PHA 
synthases, PHA depolymerases, regulatory proteins, and phasins.  PHA is stored as 
granular inclusions in the cytoplasm and can make up over 80% of a bacteria’s dry 
weight(13).  Two predominant models for in vivo granule formation have been 
proposed(14) and the resulting granule structure has been characterized(15).  Figure 
1.2 depicts the general process of granule formation in which PHA synthase binds its 
substrate and then dimerizes before elongation of the PHA chain.  Because PHA is 
water insoluble, polymerizing PHA synthase dimers exhibit an amphiphilic character 
and begin to coalesce via hydrophobic interactions between the polymer chains.  This 
structure eventually takes a granular shape in which PHA synthase remains at the 
granule surface and continues polymerize PHA into the granule core.  Available 
granule surface provides docking space for other GAPs which are regulated based on 
their affinity to the granule surface and the space available on the granule surface for 
their binding(16). 
At least 91 different repeat units occur in PHAs(17), and over 90 genera of 
bacteria, both Gram-negative and Gram-positive, have been found that produce 
PHA(18).  Among the most common PHAs is poly(3-hydroxybutyrate) (PHB) that is 
formed by PHA synthase from the substrate 3-hydroxybutyryl coenzyme A (3HB-
CoA) and whose side chain (R in Figure 1.1) is a methyl group.  
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Figure 1.1: Polyhydroxyalkanoates formula 
Among polyhydroxyalkanoates (PHAs), poly(3-hydroxybutyrate) (PHB) is the most 
common.  For PHB, R = CH3 and x = 1.  The molecular weight of in vitro polymerized 
PHB is on the order of 12 MDa(19), i.e. n ~ 141042.  
R	  =	  H,	  CH3,	  C2H5,	  C3H7	  –	  C13H27	  
	  
x	  =	  1	  –	  4	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Figure 1.2: Model for in vitro PHA granule formation 
(I) PHA synthase binds its substrate and then dimerizes before (II) elongation of the 
PHA chain.  Because PHA is water insoluble, polymerizing PHA synthase dimers 
exhibit an amphiphilic character causing them to aggregate via hydrophobic 
interactions between the polymer chains.  The resulting structures eventually take a 
granular shape (III) stabilized by PHA synthase that remains on their surface.  
Collisions between these nascent granules cause them to combine resulting in the 
formation of mature granules (IV) where PHA synthase on the surface of the granule 
continues polymerize PHA into the granule core(14, 15).  
I	   	   	   	  	  	  	  	   	   	  	  	  	  	  	  	  	  II	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	   	   	   	   	   	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  IV	  	   	   	   	   	  	  	  	  	  	  	  	  III	  
PHA	  synthase	  
PHA	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PHAs have drawn considerable attention as a potential substitutes for 
petrochemical-based plastics(18).  Much effort has focused on tailoring the physical 
properties of bulk PHA-based plastics to match those of commodity materials such as 
polypropylene through modifying PHA synthase(20, 21), tailoring substrates(21), and 
incorporating additives(22, 23).  Commercial efforts to commoditize PHA-based 
materials are well under way(24). 
1.2.   PHB biodegradation and biocompatibility 
PHAs degrade to water and carbon dioxide in the environment via 
hydrolysis(25).  In vivo, initial degradation has been shown to be caused by hydrolysis 
followed by macrophage-induced enzymatic attack(26).  PHB degrades to (D)-3-
hydroxybutyric acid in vivo, which is a constituent of human blood(27).  (DL)-3-
hydroxybutyrate has even been used as a nutritional supplement for obese subjects on 
low-energy diets or undergoing therapeutic starvation(28).  Administration of PHB in 
vivo has shown low toxicity and in fact, PHB itself has been found to be a ubiquitous 
component in human blood(29).  Several studies have investigated cell interactions 
with solvent-cast PHB both in animals and in animal cell cultures and have shown 
favorable biocompatibility of the material(30-32).  In our laboratory’s own studies, 
Niamsiri, et al. observed the biocompatible properties of surface polymerized PHB 
using mouse embryonic fibroblast cells(33).  In these studies, PHB was shown to 
promote cell attachment and growth when compared to unmodified planar gold 
surfaces.   
Overall, studies have shown that PHAs perform favorably in clinical 
applications(34).  These studies have demonstrated the biocompatibility of PHAs and 
the polymers are now being incorporated in products such as sutures, bandages, and 
implants(35). 
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1.3.   PHB granules 
Recently, the use of PHB in its granule form has emerged as a promising new 
nanoparticle for biomedical applications and these advances have been recently 
reviewed(15).  Thus far, most of PHB granule functionalization strategies have 
employed in vivo self-assembly using GAP-fusion constructs(36-45) or modification 
of the granule post-synthesis where either extracted in vivo produced granules were 
directly modified with GAP-tagged proteins or extracted PHB bulk material was used 
to produce synthetic PHB beads that were then modified with GAP-tagged 
proteins(46-49).  An additional avenue for developing functional PHB nanoparticles 
employed chemical addition of functional groups to the PHB polymer chain of 
extracted PHB(50, 51).  Furthermore, because PHA synthase is the only GAP that is 
required for granule formation(19), in vitro production of PHB granules using PHA 
synthase-fusion proteins provides a straight forward means of producing 
functionalized PHA granules(52).  These modified PHB granules have shown promise 
in protein purification systems, immunedetection, and drug delivery(15).  Table 1.1 
summarizes the various approaches to PHB granule functionalization and their 
respective applications and a review of these functionalization approaches follows:  
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Medium 
Granule 
formation 
Functionalization 
strategy Application 
in vivo 
Self-assembly 
Phasin fusion 
Protein purification(36, 37) 
FACS (38) 
ELISA(38) 
Fluorescence 
microscopy(38) 
PHA synthase fusion 
Fundamental research(39) 
Biocatalyst*(40, 41) 
IgG purification from 
Serum(42) 
Antigen purification*(43) 
ELISA(38, 41) 
DNA purification(41) 
FACS(38, 41, 44) 
Contrast agent*(45) 
Fluorescence 
microscopy(38) 
in vitro 
PHA synthase fusion Drug delivery*(52) 
Synthetic 
PHA synthase fusion Drug delivery*(53) 
Phasin fusion Protein purification(46) Fertilizer*(47) 
PHA depolymerase 
fusions 
Immunoassay(48) 
Drug delivery*(49) 
Protein microarrays*(49) 
Protein purification*(49) 
Polymer modification Gene therapy(50, 51) 
 
Table 1.1: PHB granule functionalization strategies and their applications 
The recent recognition of PHB granules as nanoparticles that can be functionalized to 
suit various applications has resulted in studies for the development of diagnostics 
and therapeutics that employ PHB granules.  Table 1.1 summarizes the various PHB 
modification strategies that have been employed to date and their respective 
applications.  The listed applications have been demonstrated in the respective cited 
references with the exception of those marked with an asterisk (*) for which the 
applications have been proposed.  
 8 
 
1.3.1. In vivo self-assembly and functionalization via GAP-fusion constructs 
1.3.1.1.Phasin fusions 
Phasins are amphiphilic GAPs that serve to stabilize PHB granules and prevent 
their coalescence as well as the nonspecific binding to their milieu(54).  The 
hydrophobic region of phasins associates with the outer surface of a PHB granule and 
can thus be exploited for the coating of granules.  Banki, et al. produced in vivo self-
assembled derivitized PHB granules by introducing two plasmids into Escherichia 
coli; one expressing three enzymes necessary for transforming metabolic acetyl-CoA 
to PHB: α-ketothiolase (encoded by the phaA gene), a stereo-specific reductase 
(phaB), and PHA synthase (phaC), and another plasmid expressing a target protein 
fused to phasin (phaP) through a self-cleaving intein(36).  In this manner, target 
protein-coated PHB granules were produced in vivo.  The authors used this system to 
purify the target protein by lysing the expressing cell then separating and cleaning the 
derivitized PHB granules before cleaving the intein and releasing the target protein.  
Barnard, et al. developed a similar protein purification system in Ralstonia eutropha, a 
natural PHB producer, thus omitting the need for introducing exogenous PHB 
production genes into the host(37). 
1.3.1.2.PHA synthase fusions 
Fusions to PHA synthase have also been utilized for the production of 
modified PHB granules in vivo.  Peters, et al. used in vivo PHB granule formation 
from PHA synthase-GFP (39) and PHA synthase-β-galactosidase(40) fusions, thereby 
producing fluorescent and enzyme-coated PHB granules.  Similarly, Brockelbank, et 
al. fused the immunoglobulin G (IgG) binding ZZ domain of protein A from S. 
aureus(42), Grage, et al. fused an anti-β-galactosidase single-chain variable fragment 
antibody(43), and Peters, et al. fused mature full length, core and monomeric 
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streptavidin to the PHA synthase(41), each imparting analyte affinity to PHA granules.  
Bäckström, et al. developed multifunctional PHB granules through PHA fusions to the 
eukaryotic mouse myelin oligodendrocyte glycoprotein (MOG) and interleukin-2(44).  
In a similar manner, multifunctional PHB granules were obtained by Jahns, et al. in 
which an IgG binding ZZ domain of protein A in addition to two genetically 
engineered proteins designed to bind gold and silica(45) were fused to PHA synthase.  
In addition, multifunctional PHB granules used in FACS, ELISA, and fluorescent 
microscopy were produced by Atwood et al. where double-fusion constructs were 
prepared with GFP and murine myelin oligodendrocyte glycoprotein fused to the N- 
and C-terminus of both PHA synthase and phasin(38). 
1.3.2. In vitro self-assembly and functionalization via GAP-fusion constructs 
1.3.2.1.PHA synthase fusions 
In addition to in vivo approaches, self-assembled modified PHB granules have 
also been produced via in vitro polymerization although only one example of this 
approach has been previously published.  Kim, et al. used purified PHA synthase 
fused to RGD peptides and produced RGD-coated granules via in vitro polymerization 
from the fusion constructs(52).  These granules were fluorescently labeled by loading 
the granule with the hydrophobic dye Nile red and were shown to specifically bind to 
breast cancer cells that constitutively express αvβ3 integrins thus showing promise as 
drug delivery vehicles. 
1.3.3. In vitro derivatization of PHB via GAP-fusion constructs 
1.3.3.1.PHA-synthase fusions 
PHA synthase fusions have also been employed in in vitro derivatization of 
synthetically produced PHB particles.  Lee, et al. developed an approach where the 
coupling between the hydrophobic surface of PHB nanoparticles and PHB chains 
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grown from PHA synthase fused with the tumor-specific ligand RGD4C allowed for 
functionalizing PHB nanoparticles(53).  PHB nanoparticles loaded with Nile red were 
prepared through a solvent evaporation method and were then functionalized by the 
addition of RGD4C-PHA synthase fusions and 3HB-CoA which decorated the PHB 
nanoparticles with the fusions due to hydrophobic interactions between the particles 
and nascent PHB chains attached to the PHA synthase.  The group demonstrated the 
specific affinity of the functionalized PHB nanoparticles to MDA-MB 231 breast 
cancer cells and proposed that this approach could be expanded as a drug-delivery 
method targeting specific cells.  
1.3.3.2.Phasin fusions 
Phasin-fusions have also been employed in the in vitro derivatization of PHB.  
Wang, et al. produced PHB granules in vitro from chemically extracted bulk PHA and 
mixed these with crude cell lysate containing phasin-tagged proteins produced in 
Escherichia coli(46).  The system was then used to purify the tagged proteins from 
crude lysates by pelleting and washing the PHB granules via centrifugation.  In 
contrast to the in vivo approach discussed in section 1.3.1.1, by separately producing 
PHB granules and the GAP-tagged protein fusions, the system could allow for the 
incorporation of a broader range of target proteins that may require eukaryotic 
expression systems.  Moldes, et al. took a similar approach in attaching phasin-fusions 
to already synthesized PHB granules, though in this case granules were extracted from 
P. putida and used directly as-synthesized by the organism(47). 
1.3.3.3.PHA depolymerase fusions 
Lee, et al. tagged green and red fluorescent proteins as well as severe acute 
respiratory syndrome coronavirus (SARS-CoV) envelope protein with the substrate 
binding domain of PHA depolymerase from A. faecalis and decorated synthetic PHB 
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beads produced from extracted PHB bulk material(48).  Similarly, Ihssen, et al. fused 
proteins to inactive extracellular PHA depolymerase from P. fluorescens and 
decorated synthetically produced granules of Poly[(3-hydroxyoctanoate)-co-(3-
hydroxyhexanoate)] derived from P. putida(49). 
1.3.4. In vitro chemical modification of PHA 
An alternative approach towards developing functional PHA granules is to 
modify the polymer backbone to include specific functional groups.  Sparks, et al. 
reported the synthetic production of the first cationic PHA, poly(β-hydroxyoctanoate)-
co-(β-hydroxy-11-(bis(2-hydroxyethyl)-amino)-10-hydroxyundecanoate) (PHON)(50) 
by chemically modifying poly(β-hydroxyoctanoate)-co-(β-hydroxyundecenoate) 
extracted from P. putida GPo1.  More recently the authors reported the use of this 
polymer as a plasmid DNA delivery system(51).   
1.4.  PHB particle-based drug delivery 
PHB associates with other macromolecules via hydrogen bonding to the 
polymer chain(55).  Cations can also coordinate with the carbonyl groups on the 
structure(55).  In addition, the spacing of electron-donating groups along the polymer 
chain allows for multiple bonding interactions which permits the binding of proteins 
and the formation of complexes with salts(27). 
Several studies have explored the potential of using PHB particles as drug 
release formulations(56, 57).  Table 1.2 outlines the use of PHB as a 
microencapsulation agent where anticancer drugs (CCNU, lastet, and 2’,3’-diacyl-5-
fluoro-2‘-deoxyuridine)(58-60), the contraceptive progesterone(61), the antimicrobials 
sulfamethizole(62) and netilmicin(27, 63), and the dyes dichlorofluoroscein(64) and 
Nile red(52) have been encapsulated. 
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The majority of microencapsulation approaches have employed solvent 
evaporation processes though encapsulation has also been demonstrated using in vitro 
PHB polymerization(27, 52, 63).  Nobes, et al. encapsulated the antibiotic netilmicin 
by dissolving netilmicin in phosphate buffer, adding 3HB-CoA, and PHA synthase(27, 
63).  The maximum encapsulation efficiency was found to be approximately 4.5%, 
comparing favorably with the encapsulation efficiency of anionic and cationic 
liposomes(65). 
The rate of release from encapsulating PHB microspheres has also been 
studied and varies widely depending on the encapsulated material.  When comparing 
the rate of release with that of poly(lactic acid), one of the most widely used 
biodegradable polymers, some materials exhibit a much higher rate of release for 
PHB(58) while others materials exhibit a very slow rate of release(59).  
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Substance 
type Substance 
Encapsulation 
process 
Size 
(µm) Release Ref 
Anticancer 
drug 
1 -(2 chloroethyl)-3-
cyclohexylnitrosourea 
Solvent 
evaporation 1-5 
90% in 
10 h (58) 
Alcarubicin Solvent evaporation 
158-
214 
10% in 
120 h (59) 
Lastet Solvent evaporation 15-25 Variable (66) 
2’,3’-Diacyl-5-fluoro-
2’-deoxyuridine 
Solvent 
evaporation 
101-
326 Variable (60) 
Retinoic acid Solvent dialysis 50 nm nd (57) 
Contraceptive Progesterone Solvent evaporation nd Variable (61) 
Vaccine Staphylococcal  enterotoxin B 
Solvent 
evaporation 1-10 Variable (67) 
Dye 
Dichlorofluorescein Solvent evaporation nd 
94% in 
3 h (68) 
Nile red 
In vitro 
polymerization 
70-600 
nm nd (52) 
Solvent 
evaporation 
~200 
nm nd (53) 
Antimicrobial 
Netilmicin In vitro polymerization nd nd 
(27, 
63) 
Sulfamethizole Solvent evaporation 
53-
2000 
50% in 
12 h (62) 
 
Table 1.2: Microencapsulated substances in polyhydroxyalkanoates 
Various substances have been microencapsulated in polyhydroxyalkanoates particles 
as potential drug release formulations.  The majority of microencapsulation 
approaches have employed solvent evaporation processes though encapsulation has 
also been demonstrated using in vitro PHB polymerization.  The rate of release from 
encapsulating PHB microspheres has also been studied and varies widely depending 
on the encapsulated material.  Table 1.2 has been adapted from Nobes, et al.(27).  
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1.5. Overview of dissertation 
PHB granules are emerging as a promising nanomaterial for a variety of 
biomedical applications.  These granules benefit from a biocompatible and 
biodegradable core that may be loaded with molecules that impart imaging and 
therapeutic capabilities and the granule surface may be modified for a wide range of 
functionalities. 
This dissertation describes the development, characterization, and potential 
applications of nanoparticle-coated PHB granules.  Chapter 2 describes the 
development of gold (AuNP) and superparamagnetic iron oxide nanoparticle 
(SPION)-PHA synthase conjugates that produce nanoparticle-coated PHB granules 
upon the addition of 3HB-CoA.  The properties and potential applications of the 
resulting nanoparticle-coated PHB granules are discussed in Chapters 3 and 4 and the 
dissertation concludes with general conclusions and future directions discussed in 
Chapter 5. 
In the past, a wide range of biomolecules have been immobilized on the 
surface of PHB granules that have allowed for using functionalized granules in 
applications ranging from protein purification(42, 105) to cancer cell targeting(44, 52).  
Of the PHB granule functionalization strategies employed to date, only one approach 
has allowed for coating PHB granules with inorganic materials(45) requiring the 
subsequent decoration of in vivo-produced and extracted granules and resulting in 
sparsely coated nanoparticle-PHB granule hybrid materials that were not further 
characterized.  In contrast to in vivo granule formation, our in vitro approach allows 
for the direct assembly of nanoparticle-coated PHB granules in a single-step process 
allowing for straightforward means of controlling PHB granule size and resulting in 
densely nanoparticle-coated PHB granules.  These improved nanoparticle-PHB 
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granule hybrid materials exhibit unique properties to those of PHB and the 
nanoparticles alone as a result of the arrangement of the nanoparticles on the PHB 
granule surface. 
The studies in this dissertation describe a novel means of producing 
nanoparticle-coated PHB granules that expands the capabilities of functionalized PHB 
granules through harnessing versatile properties of inorganic nanoparticles.  The 
SPION-coated PHB granules that are potential MRI contrast agents with enhanced 
imaging capabilities afforded by PHB mediated aggregation of SPION that resulted in 
SPION-coated PHB while AuNP-coated PHB granules are potential theranostic agents 
that have enhanced imaging capabilities and are also capable of heating upon near-
infrared (NIR) laser irradiation.  In general, both of these materials may be suitable as 
multifunctional theranostic agents with imaging (MRI, fluorescence/SERS, enhanced 
fluorescence) and therapeutic (drug delivery/photothermal heating) capabilities.  
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Chapter 2 – Nanoparticle-PHA synthase conjugates  
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2.1.  Abstract 
Polyhydroxyalkanoate (PHA) synthase was conjugated to gold nanoparticles 
(AuNP) and superparamagnetic iron oxide nanoparticles (SPION) resulting in PHA 
synthase-nanoparticle conjugates with a hydrodynamic diameter of ~45 nm as 
determined via dynamic light scattering.  Upon the addition of 3-hydroxybutyrate-
CoA (3HB-CoA), these nanoparticle-PHA synthase conjugates produced poly(3-
hydroxybutyrate) (PHB) and then coalesce to form nano- to micron-sized 
nanoparticle-coated PHB granules.  The granule formation mechanism is thought to 
occur in a manner analogous to native in vitro PHB granule formation in which PHA 
synthase remains on the granule surface.  The nanoparticle-PHA synthase conjugates 
described in this work offer a novel means of producing nanoparticle-coated PHB 
granules that may exhibit useful physical properties derived from their nanoparticle-
coating. 
2.2.  Introduction 
Previous work in the Batt laboratory has employed PHA synthase through 
enzymatic surface initiated polymerization (ESIP) for applications in bottom-up 
nano/microfabrication on a variety of micropatterned surfaces as well as on 
microbeads(8, 69-73).  In this prior work, the introduction of a histidine tag to PHA 
synthase also allowed for the site-specific and reversible functionalization of the 
enzyme onto surfaces via their modification with nickel nitrilotriacetate (Ni-NTA).  
Kim, et al. constructed PHB-coated agarose microbeads from Ni-NTA derivitized 
agarose beads resulting in uniformly coated structures(70, 71).  Additionally, PHB 
could be released from the bead surface by the addition of imidazole, which out-
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competes the imidazole side chains of histidine bound to Ni-NTA thus releasing the 
His-tagged PHA synthase along with the PHB polymer chain. 
In this current study, we thought to expand our repertoire of ESIP-derived 
structures by functionalizing nanoparticles with PHA synthase, providing a novel 
platform – nanoparticles – from which to polymerize PHB.  Based on the natural PHB 
granule structure (Figure 1.2), those produced from nanoparticle-PHA synthase 
conjugates were expected to result in nanoparticle-coated granules that would lead to 
the possibility of exploiting effects caused by the nanoparticle aggregation on the 
granule surface.  Gold and superparamagnetic iron oxide nanoparticles (AuNP and 
SPION, respectively) were first conjugated to PHA synthase and PHB polymerization 
was then initiated from these conjugates resulting in nanoparticle-coated PHB 
granules. 
AuNP and SPION were chosen based on their respective properties that make 
these materials candidates for a wide range of advanced diagnostic and therapeutic 
applications.  These properties are summarized below: 
2.2.1. SPION: MRI contrast enhancement 
Local variations in the magnetic properties within a medium give rise to MRI 
contrast gradients arising from variations in the transverse relaxation times (T2) of 
nearby protons.  Tissue susceptibility gradients may exist when either endogenous or 
exogenous paramagnetic materials accumulate locally within tissues.  Endogenously 
occurring paramagnetic substances include deoxyhemoglobin, methemoglobin, 
hemosiderin, melanin, and ferritin(74).  Exogenous materials such as 
superparamagnetic iron oxide-based contrast agents consist of suspended colloids of 
iron oxide nanoparticles that shorten the T2 relaxation times of absorbing protons in 
tissues thereby enhancing the MR contrast of these tissues(75).  A single SPIO particle 
consists of large amounts of iron and results in several orders of magnitude higher 
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relaxivities than the more common gadolinium-based contrast agents.  SPIO 
nanoparticles are among the few FDA approved nanomaterials and several SPION, 
typically 50 nm in diameter, are currently in clinical use as MRI contrast agents(76). 
2.2.2. AuNP: optical and photothermal properties 
2.2.2.1.Raman spectroscopy 
Raman spectroscopy is a branch of vibrational spectroscopy in which the 
transitions between molecular vibrational states are studied using the scattered 
radiation produced when a molecule absorbs a photon of light(77).  A valuable 
extension of Raman spectroscopy is derived from a substantial Raman signal 
enhancement factor (on the order of 106) that can be achieved when molecules are 
physisorbed or chemisorbed to metallic nanostructures(78).  The enhancement is 
primarily derived from an increase in the electric field around the molecule due to 
surface plasmon resonances (SPR) generated by the excitation of conduction electrons 
on the surface of nanoparticles(79, 80).  Gold and silver are typical metals for SERS 
experiments because their SPR frequencies fall within wavelengths of visible and NIR 
light(81). 
2.2.2.2.Enhanced fluorescence 
In contrast to SERS phenomena, when a fluorophore is localized to metal 
particles or surfaces at less than ~5 nm, its emission is quenched by energy transfer to 
the metal(82).  However, at further distances (between 5 and 70 nm), increases in 
fluorescence by factors of up to 1000 can be observed(82-85).  Two phenomena can 
contribute to this fluorescent enhancement including surface enhanced fluorescence 
(SEF) in which the metal particles concentrate the local excitation intensity and metal 
enhanced fluorescence (MEF) in which the electric field felt by a fluorophore is 
affected by interaction of the fluorophore oscillating dipole with the metal surface(85-
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88).  In the latter case, there is an increase in the radiative rate of the fluorophore that 
results in an increased intensity and, since the fluorophore will spend less time in the 
excited state for each excitation, the extent of photobleaching of the fluorophore also 
decreases. 
2.2.2.3.Photothermal heating 
AuNPs usually exhibit a significant absorption peak from 500 to 550 nm, due 
to their surface plasmon that arises from the oscillation of the valence electrons in 
resonance with incident photons(81).  The resonating surface plasmon decays by 
radiating its energy resulting in light scattering or conversion of absorbed light to 
heat(89).  This later nonradiative component of the extinction is efficiently converted 
via electron-electron and electron-phonon relaxations to heat on the order of 
picoseconds(90-93) allowing for localized heating of the medium immediately 
surrounding the nanoparticle(94).  As a result, AuNPs can convert absorbed light to 
heat at efficiencies that are far greater than that of conventional dyes(95).  A particular 
advantage of using gold nanoparticles in photothermal applications is the possibility of 
using an NIR illumination source that exploits the 'water window' in the wavelength 
regions between 600-1100 nm.  At these wavelengths there is a lack of efficient 
endogenous absorbers in cells and tissues allowing for high light penetration depth and 
decreased laser damage to non-target tissue(96, 97). 
2.3. Experimental 
2.3.1. Expression and purification of PHA synthase 
His10-tagged PHA synthase of Ralstonia eutropha H16 (DSM428) (His10-
tagged PhaCRe) was expressed from a recombinant Escherichia coli strain developed 
using the BL21 (DE3) pLysS (Novagen)/pET-CO1 expression system (EMD 
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Chemicals Inc./Merck KGaA, Darmstadt, Germany) as described elsewhere(69).  
Overnight cultures from frozen recombinant Escherichia coli stocks were first grown 
at 37°C on solid LB media containing 100 µg/mL of ampicillin.  Overnight liquid 
cultures were then grown from single colonies taken the overnight cultures and used to 
inoculate 5 mL of LB and 100 µg/mL of ampicillin incubated shaking at 250 RPM and 
at 37°C.  This 5 mL pre inoculum was then used to inoculate 500 mL of LB containing 
100 µg/mL of ampicillin.  The 500 mL cultures were grown in a shaking incubator at 
37°C and 250 RMP to an OD600nm of 0.4-0.6 (1-3 hrs) and then induced to express 
PHA synthase with the addition of 200 µM isopropyl β-D-1-thiogalactopyranoside 
(IPTG).  After culturing the cells for an additional 5 hrs in a shaking incubator at 30°C 
and 250 RMP, the cells were pelleted by centrifugation (4,000 x g, 10 min, 4°C), the 
supernatant was discarded and the cell pellet was resuspended in lysis buffer (50 mM 
Na-phosphate buffer, pH 7, 10 mM imidazole).  Following resuspension, the cells 
were homogenized (Emulsiflex-C3, Avestin, Ottawa, Canada) with the addition of 
DNAse (TURBO, DNAse, Applied Biosystems, Carlsbad, CA), centrifuged (13,000 x 
g, 30 min, 4°C), and the cell lysate supernatant was collected and filtered using a 0.22 
µm vacuum filter.  The filtrate was then combined with Ni(II)-charged immobilized 
metal ion chromatography (IMAC) resin (Chelating Sepharose Fast Flow, GE 
Healthcare, Uppsala, Sweden) at a volume to volume ratio of 1:4 (resin:lysate), and 
allowed to mix for 15 min at room temperature with gentle rocking.  The lysate-resin 
mix was then placed in a glass gravity-flow column and the flow-though was eluted 
and collected.  The resin was washed with 2-column volume of lysis buffer and 4 
column volumes of wash buffer (50 mM Na-phosphate buffer, pH 7, 20 mM 
imidazole).  One column volume of elution buffer (50 mM Na-phosphate buffer, pH 7, 
300 mM imidazole) was then added to the washed resin and allowed to mix in the 
column for 15 min at room temperature.  The flow-though was then eluted and another 
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column volume of elution buffer was added to the column and immediately allowed to 
flow though.  Next, an additional column volume of elution buffer was added to the 
column flowed through the column with the addition of pressure using a 20 cc syringe.  
All washes and elutions were collected for analysis via SDS-PAGE and Western blot. 
The total amount of purified protein was determined via the Bradford assay 
following the manufacturer’s protocol (Bio-Rad Protein Assay, Bio-Rad Laboratories, 
Hercules, CA).  The purity of PHA synthase was analyzed by SDS-PAGE and elution 
fractions at greater than 50% purity were concentrated to 1 mg/mL by centrifugation 
using 30 kDa-cutoff spin filter units (Amicon Ultra-15 Centrifugal Filter Unit with 
Ultracel-30 membrane, Millipore, Billerica, MA).  The concentrated purified PHA 
synthase was then buffer exchanged from elution buffer into 50 mM Na phosphate 
buffer, pH 7 via size exclusion chromatography (SEC). 
Size exclusion chromatography was performed using a C 16/70 column packed 
with Superdex 200 resin connected to an AKTÄ Explorer fast protein liquid 
chromatography system (GE Healthcare, Uppsala, Sweden).  The column was 
calibrated using Aqueous SEC 1 protein molecular weight standards following the 
manufacturer’s protocol (Phenomenex, Torrance, California).  The mobile phase was 
50 mM Na phosphate buffer, pH 7, the flow rate was 1 mL/min, and sample injections 
were 500 µL. 
2.3.2. Synthesis of 3HB-CoA 
3HB-CoA was synthesized from the reaction of β-butyrolactone with free 
coenzyme A (CoA) following the method of Simon, et al.(98).  Twenty five mg (32.6 
µmoles) of coenzyme A lithium salt (Sigma Aldrich, St. Louis, MO) was dissolved in 
1.25 mL of a 0.2 M KHCO3 solution within a glass container including a magnetic stir 
bar.  The container was placed in an ice bath and 28 mg (326 µmoles) of β-
butyrolactone (molar ratio of CoA to lactone 1:10) was dripped into the container 
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while stirring.  Following Song, et al.(99), the reaction was allowed to continue for 
120 min then excess lactone was removed by three extractions with ether.  The 
solution was then lyophilized and stored at -20°C. 
Ellman’s reagent, 5,5’-dithiobis(2-nitrobenoic acid) (DNTB) (Thermo Fisher 
Scientific, Rockford, IL), was used for determining the concentration of free CoA in 
the final reaction solution to determine the yield of the reaction (see In vitro 
Polymerization of 3HB-CoA). 
2.3.3. Nanoparticle synthesis 
2.3.3.1.SPION 
Particles were synthesized following Sun, et al. Briefly, Fe3O4 nanoparticles 
were made mixing Fe(acac)3 (2 mmol) in phenyl ether (20 mL), 1,2-hexadecanediol 
(10 mmol), oleic acid (6 mmol), and oleylamine (6 mmol) under nitrogen then heating 
to 260oC and refluxed for 30 minutes(76).  After cooling to room temperature, black 
colored magnetite crystals were isolated by adding an excess amount of ethanol 
followed by centrifugation.  The ethanol was then discarded and the precipitant dried 
at room temperature.  The dried SPIO particles were then resuspended in chloroform 
at a concentration of 50 mg/mL and stored at -20 °C. 
2.3.3.2.AuNP 
Particles were synthesized following Presa, et al. Briefly, Au nanoparticles 
were made mixing gold acetate Au(ac)3 (0.27 mmol), 1,2- hexadecanediol (1.9 mmol), 
and phenyl ether (30 mL) in a three neck flask then heating to 80°C under N2 before 
adding oleic acid (1 mmol) and oleylamine (1 mmol) then refluxing at 260°C for 30 
min(100).  After cooling to room temperature, purple colored gold crystals were 
isolated by adding an excess amount of ethanol followed by centrifugation.  The 
ethanol was then discarded and the precipitant dried at room temperature.  The dried 
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Au particles were then resuspended in chloroform at a concentration of 50 mg/mL and 
stored at -20°C. 
2.3.4. Nanoparticle functionalization 
The nanoparticle functionalization is depicted in Figure 2.1.  Oleic 
acid/oleylamine-coated nanoparticles were made water soluble following Dubertret, et 
al.(101).  Briefly, 17 mg of nanoparticle-oleic acid/oleylamine in chloroform was 
mixed with 5.5 µmoles of 1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine-N-
[Carboxy(Polyethylene Glycol)2000] (PL-PEG-COOH) (Avanti Polar Lipids, 
Alabaster, AL) in chloroform.  PL-PEG-COOH consists of phospholipids attached to 
45-unit polyethylene glycol (PEG) with a carboxylic acid at its terminus that can be 
used for further chemical modification.  The mixture was sonicated in a bath sonicator 
(Branson Sonifier 250, Branson Ultrasonics, Danbury, CT) (200 watts, 30 min) and 
was then placed in a fume hood until the chloroform was completely evaporated.  
Next, 1 mL of reagent grade water (Nerl Diagnostics, East Providence, RI) was added 
and the mixture was again sonicated for 30 min and the resulting suspension was 
ultracentrifuged at 500,000 x g for two hrs to remove empty phospholipid micelles.  
The supernatant was then discarded and the pellet was reconstituted in 1 mL of 
reagent grade water then passed through a 0.1 µm filter to remove aggregates and the 
suspension was then stored at 4°C. 
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Figure 2.1: Nanoparticle functionalization 
The figure depicts the composition and structure of nanoparticle-PHA synthase 
conjugates employed in this study.  Oleic acid/oleylamine-coated nanoparticles 
(orange shaded area) were made water soluble through coating the particles with 
carboxy-terminated PEGylated phospholipids (blue area).  The carboxyl groups on 
the surface of these now water soluble particles were then converted to primary 
amine-reactive NHS-esters which were subsequently reacted with PHA synthase 
forming a covalent bond between the PEG on the particle and primary amines of PHA 
synthase (green area).  The dimensions of these structures are outlined in Figure 2.8.  
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Next, the carboxyl groups of the nanoparticle-PL-PEG-COOH were converted 
to primary amine-reactive NHS-esters using 1-ethyl-3-[3-dimethylaminopropyl] 
carbodiimide hydrochloride (EDC) and NHydroxysulfosuccinimide (sulfo-NHS) 
(Thermo Fisher Scientific, Rockford, IL).  Briefly, an aliquot containing of 
nanoparticle-PL-PEG-COOH was added to 0.1 M (2-(N-morpholino)ethanesulfonic 
acid) (MES) and 9% NaCl at pH 4.7.  EDC and sulfo-NHS were then added to this 
mixture at 4 mM and 10 mM, respectively at a final volume of 0.5 mL and the mixture 
was allowed to react for 30 min at room temperature.  Excess EDC and sulfo-NHS 
was then removed separated from nanoparticle-PL-PEG-NHS-ester via size exclusion 
with 50 mM Na-phosphate buffer at pH 7 as the mobile phase and the purified 
particles were concentrated to 0.5 mL using a 30 kDa spin column.  Immediately after 
purification, the nanoparticle-PL-PEG-NHS-ester suspension was mixed with PHA 
synthase in 50 mM Na-phosphate buffer at pH 7 at a 1:1 nanoparticle:PHA synthase 
mass to mass ratio.  This mixture was allowed to react for two hours at room 
temperature then excess unconjugated protein was separated from nanoparticle-PL-
PEG-PHA synthase conjugates via SEC with 50 mM Na-phosphate buffer at pH 7 as 
the mobile phase.  Finally, the purified conjugates were again concentrated to 0.5 mL 
using a 30 kDa spin column. 
2.3.5. Particle size analysis 
The sizes of the nanoparticle cores were determined by transmission electron 
microscopy (TEM) and dynamic light scattering (DLS).  Transmission electron 
microscopy was conducted using a Philips EM-201 (Royal Philips Electronics, 
Amsterdam, Netherlands) operating at 80 keV.  Samples were prepared for imaging by 
dipping 200 mesh copper formvar coated grids stabilized with evaporated carbon 
(Electron Microscopy Sciences, Hatfield, PA) in 5 uL drops of sample for 30 min 
followed by washing the grid by dipping it in reagent-grade water then drying the grid 
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by wicking away excess liquid.  Dynamic light scattering measurements were 
performed on a Zetasizer Nano ZS system (Malvern Instruments, Worcestershire, 
United Kingdom).  Samples were passed through a 0.22 µm filter prior to placement in 
1 mL polypropylene cuvettes for measurement.  Measurement results of the most 
abundant species in the sample were summarized by the number statistics analysis 
performed by the Zetasizer software. 
TEM image analysis was performed using Image J (National Institutes of 
Health, Bethesda, Maryland).   Because the TEM samples are unstained, only the 
electron-dense AuNP and SPION cores can be readily observed in the TEM image.  
Particles were analyzed using Image J’s particle analysis feature in which a threshold 
was first set that resolved the nanoparticles then the diameters of nanoparticles were 
determined for particles selected by the software.  The particle selection criteria 
screened for particles with a circularity of 0.9, defined as the following: circularity = 4 
π (area/perimeter2), where a circularity value of 1.0 indicates a perfect circle and 
values approaching zero indicate an increasingly elongated polygon.  This value of 
circularity was chosen to avoid counting closely spaced particles as a single large 
particle and furthermore, the results of the analysis were verified visually to ensure 
only individual particles were included in the measurement.   
The resulting size distribution data of 100 particles was summarized as a 
histogram with the bin size chosen using a histogram bin size optimization tool 
developed by Shimazaki (2010)(102).  The histogram data for each measurement was 
then plotted using OriginPro 7.5 (OriginLab Corporation, Northampton, MA) and fit 
using OriginPro’s non-linear curve fitting feature employing the software’s peak 
function algorithms.  Fits for which the resulting coefficient of determination was 
closest to a value of 1 were chosen used to determine the median nanoparticle size. 
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The diameter of nanoparticles coated with oleic acid/oleylamine, PL-PEG-
COOH, and PL-PEG-PHA synthase were all measured via DLS using the appropriate 
buffer (chloroform or 50 mM sodium phosphate buffer, pH 7).  The DSL instrument 
provided a histogram of the diameters of the most abundant species in the sample with 
the bin size automatically chosen by the instruments algorithm.  The resulting 
histogram data for each measurement was then plotted using OriginPro 7.5 and fit 
using OriginPro’s non-linear curve fitting feature employing the software’s peak 
function algorithms.  Fits for which the resulting coefficient of determination was 
closest to a value of 1 were chosen used to determine the median nanoparticle size. 
2.3.6. In vitro polymerization of 3HB-CoA 
In vitro polymerization of PHB from nanoparticle-PL-PEG-PHA synthase 
conjugates was carried out by mixing samples of nanoparticle-PL-PEG-PHA synthase 
suspended in 50 mM Na-phosphate buffer, pH 7 with 3HB-CoA dissolved in reagent-
grade water to a final 3HB-CoA concentration of 2.5 mM.  The mixtures were allowed 
to react for two hours at room temperature.  For samples prepared for fluorescent 
microscopy analysis of polymerization, Nile red dissolved in DMSO was also added 
along with 3HB-CoA to a final Nile red concentration of 50 µg/mL. 
2.4. Results and discussion 
2.4.1. Nanoparticle synthesis 
The SPIO and gold nanoparticle synthesis produced oleic acid/oleylamine-
coated particles with a median core diameter of 3.45 nm for SPION (Figure 2.2A) and 
5.05 nm for AuNP (Figure 2.2B) as determined via TEM.  The median diameter of the 
oleic acid/oleylamine-coated particles was measured to be 9.25 nm for SPION (Figure 
2.3A) and 9.50 nm for AuNP (Figure 2.3B) as determined by DLS, a size increase that 
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is consistent taking into account a monolayer coating of oleic acid/oleylamine around 
the nanoparticles (1.8 nm) and the chloroform solvent layer (0.64 nm).   
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Figure 2.2: Nanoparticle core diameter 
The diameters of 100 nanoparticle cores were determined via TEM image analysis 
using Image J’s particle analysis algorithm.  The resulting size distribution data is 
summarized as a histogram with the bin size chosen using a histogram bin size 
optimization tool(102).  A peak function fit of the data for which the resulting 
coefficient of determination was closest to a value of 1 was used to determine a 
median particle size.  Based on the curve fit, the median SPION core diameter (A) was 
determined to be 3.45 nm and the median AuNP core diameter (B) was determined to 
be 5.05 nm.  
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Figure 2.3: Nanoparticle-oleic acid/oleylamine diameter 
The diameters of as-synthesized oleic acid/oleylamine-coated nanoparticles suspended 
in chloroform were measured via dynamic light scattering that provided a histogram 
of the diameters of the most abundant species in the sample with the bin size 
automatically chosen by the instruments algorithm.  A peak function fit of the data for 
which the resulting coefficient of determination was closest to a value of 1 was used to 
determine a median particle size.   Based on the curve fit, the median diameter of the 
oleic acid/oleylamine-coated SPION (A) was determined to be 9.25 nm and the 
median diameter of the oleic acid/oleylamine-coated AuNP (B) was determined to be 
9.50 nm.  
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2.4.2. Nanoparticle-PL-PEG-COOH Functionalization 
After encapsulation of the oleic acid/oleylamine nanoparticles with carboxy-
terminated PEGylated phospholipids (PL-PEG-COOH) the median particle size now 
increased to 44.5 nm for SPION (Figure 2.4A) and 45.0 nm for AuNP (Figure 2.4B) 
as measured by DLS, a size increase that is consistent with the coating of fully 
extended PL-PEG-COOH (16.7 nm) and the water solvent layer (0.25 nm).  See 
Figure 2.8 for a summary of the expected and measured size of the nanoparticles at 
each step in the functionalization process. 
2.4.3. PHA synthase preparation 
When the PHA synthase elution fraction from IMAC purification were 
processed via SEC, three peaks appearing at ~512 kDa, ~69 kDa, and ~6.5 kDa were 
observed in the chromatogram (Figure 2.5).  SDS PAGE and Western blot analysis of 
fractions collected from each of these peaks revealed that both the ~512 kDa and ~69 
kDa peaks contained PHA synthase.  The ~69 kDa peak includes the His-tagged PHA 
synthase monomer (~67.5 kDa) while the ~512 kDa peak includes PHA synthase 
aggregates.  PHA synthase is known to dimerize, however, these aggregates were 
would apparently comprised of 7-8 monomers based on molecular weight and are 
perhaps instead due to aggregates including endogenous PHB produced by the 
Escherichia coli host(103).  This observation lead us to only collect the monomer peak 
for further processing while discarding the aggregate peak as the aggregate peak 
would otherwise co-elute with nanoparticle-PHA synthase conjugates during 
subsequent SEC steps and thus result in the possibility of not removing unconjugated 
PHA synthase (Figure 2.6).  Separation of these aggregates ensures that no 
unconjugated PHA synthase is present in the sample since free PHA synthase can 
contribute to the formation of PHB granules devoid of nanoparticles.  The collected 
 33 
monomeric PHA synthase remained in its un-aggregated form for at least 24 hrs of 
storage in 50 mM Na phosphate buffer, pH 7 as confirmed by subsequent SEC.  For 
two separate runs, the average amount of enzyme lost due to the discarding of 
aggregates during the purification process was 42% of the IMAC-purified material as 
determined by SDS-PAGE and densitometry. 
2.4.4. Nanoparticle-PHA synthase conjugation 
Functionalization of the PEG-COOH-coated nanoparticles with PHA synthase 
yielded particles with a median diameter of 45.2 nm for SPION (Figure 2.7A) and 
46.8 nm for AuNP (Figure 2.7B) as determined via DLS.  This size increase does not 
reflect an expected particle growth from the addition of PHA, where at 67.5 kDa and 
assuming a globular conformation, a PHA hydrodynamic diameter of 7.2 nm (estimate 
based on the Zetasizer software Protein Analysis Utility) would lead to a nanoparticle 
conjugates having a diameter of ~54-56 nm (Figure 2.8).  A likely explanation for this 
discrepancy is that the number of PHA synthase per particle is not homogenous and 
the observed size distribution is comprised of a mixture of particles with and without 
conjugated PHA synthase.  Similar to nanoparticle-PL-PEG-COOH, these DLS and 
TEM observations indicate that nanoparticle-PL-PEG-PHA synthase particles consist 
of individual and un-aggregated particles in solution which is an important 
characteristic since starting with un-aggregated nanoparticle-PHA synthase conjugates 
prior to polymerization allowed for studying aggregation-derived phenomena upon 
aggregation mediated by PHB polymerization from the conjugates as described in 
Chapters 3 and 4.  
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Figure 2.4: Nanoparticle-PL-PEG-COOH diameter 
The diameters of carboxy-terminated PEGylated phospholipid-coated nanoparticles 
suspended in deionized water were measured via dynamic light scattering that 
provided a histogram of the diameters of the most abundant species in the sample with 
the bin size automatically chosen by the instruments algorithm.  A peak function fit of 
the data for which the resulting coefficient of determination was closest to a value of 1 
was used to determine a median particle size.  A) The median diameter of carboxy-
terminated PEGylated phospholipid-coated SPION was determined to be 44.5 nm.  B) 
The median diameter of carboxy-terminated PEGylated phospholipid-coated AuNP 
was determined to be 45.0 nm.  
0 50 100 150 200 250
0
9
18
27
Fit: R2 = 0.9977
Median: 45.0 nm
N
um
be
r (
%
)
Diameter (nm)
0 20 40 60 80 100 120 140
0
2
4
6
8
10
12
14
16
18
20
22
24
Fit: R2 = 0.99466
Median: 44.5 nmN
um
be
r (
%
)
Diameter (nm)
A	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  B	  
	  
	  
	  
	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  SPION	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  AuNP	  
 35 
 
Figure 2.5: Size exclusion chromatography of IMAC-purified PHA synthase 
IMAC-purified PHA synthase was processed via SEC, the chromatogram of which 
revealed three peaks appearing at ~512 kDa, ~69 kDa, and ~6.5 kDa based on a 
three-peak Gaussian fit of the chromatogram data (green and red traces, R2 = 
0.99775).  Both the ~512 kDa and ~69 kDa peaks contained PHA synthase as 
determined by Western blot analysis of SDS PAGE processed IMAC-purified material, 
the smaller of which is derived from PHA synthase monomer.   
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Figure 2.6: Size exclusion chromatography of PHA synthase and nanoparticles 
IMAC-purified PHA synthase (red trace), PHA synthase monomer (blue trace), and 
nanoparticle-PHA synthase conjugates (black trace) were each processed by SEC.  
The figure shows each SEC chromatogram superimposed where it can be seen that 
PHA synthase aggregates (first peak in the red trace) co-elute with nanoparticles 
while PHA synthase monomer does not.  In order to ensure that nanoparticle-PHA 
synthase conjugate material did contain un-conjugates PHA synthase, PHA synthase 
monomer was used in the conjugation reaction that was subsequently processed via 
SEC, discarding material that eluted after the nanoparticle peak.   
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Figure 2.7: Nanoparticle-PHA synthase diameter 
The diameters of PHA synthase-conjugated nanoparticles suspended in phosphate 
buffer were measured via dynamic light scattering that provided a histogram of the 
diameters of the most abundant species in the sample with the bin size automatically 
chosen by the instruments algorithm.  A peak function fit of the data for which the 
resulting coefficient of determination was closest to a value of 1 was used to determine 
a median particle size.  A) Functionalization of the PEG-COOH-coated SPION with 
PHA synthase yielded particles with a median diameter of 45.2 nm.  B) 
Functionalization of the PEG-COOH-coated AuNP with PHA synthase yielded 
particles with a median diameter of 46.8 nm.  
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Figure 2.8: Summary of nanoparticle size analysis during functionalization 
The expected (red text) and measured (blue text) diameters of the nanoparticles at 
each step of the functionalization process are summarized for both SPION (A) and 
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AuNP (B).  Numbers in black text are the estimated sizes contributed by each 
component comprising the different materials coating the nanoparticles.  All numbers 
are in units of nanometers.  Discrepancies between expected and measured results of 
less than 4 nm were observed with the exception of the expected size increase after the 
conjugation of PHA synthase to the nanoparticles where measured results where ~10 
nm smaller than expected.  A likely explanation for this discrepancy is that the number 
of PHA synthase per particle is not homogenous and the observed size distribution is 
comprised of a mixture of particles with and without conjugated PHA synthase.   
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2.4.5. Synthesis of 3HB-CoA 
The yield of 3HB-CoA synthesis from a single run was determined to be 46% 
as determined from Ellman’s reagent assay.  Under the reaction conditions, 100% of 
the free coenzyme A (32.6 µmoles) was expected to have reacted(99) thus based on 
the yield of 3HB-CoA, up to 54% (17.6 µmoles) of free coenzyme A remained in the 
product, likely due to 3HB-CoA hydrolysis during the reaction and processing or due 
to loss of product during the ether extraction of excess lactone.  In order to minimize 
the loss of 3HB-CoA due to its hydrolysis(98), the ether extraction of excess lactone 
was the only purification step performed.  Thus, in addition to 3HB-CoA, the final 
product was likely to contain up to 17.6 µmoles of free coenzyme A based on the 
measured yield and some amount of 4-hydroxybutanoic acid from hydrolyzed β-
butyrolactone as well as 0.2 M KHCO3.  Of these constituents, only free coenzyme A 
could cause deleterious effects to PHB granule formation as it is known to inhibit 
PHA synthase activity(104).  Nevertheless, the product of this reaction allowed for 
PHB polymerization in our studies. 
2.4.6. Production and properties of nanoparticle coated PHB 
Upon the addition of 3HB-CoA to nanoparticle-PHA synthase conjugates, 
PHB polymer was formed and grew to polydisperse spherical granules with diameters 
up to 1500 nm in diameter (see Figure 2.9 A-C for SPION-PHB granules and Figure 
2.10 A-C for AuNP-PHB granules).  As can be seen in the TEM images, these 
granules are coated with nanoparticles that appear as round structures with dark spots 
derived from electron-dense nanoparticles on their surface.  The incorporation of 
nanoparticles within the PHB granule was not observed through our TEM analysis and 
it is possible that the nanoparticle-coated granules only result from a population of 
nanoparticle-PHA synthase conjugates that have few PHA synthase per nanoparticle; 
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in this case, PHA synthase would have less steric hindrance and can more easily 
participate in granule formation. 
The presence of PHB was also confirmed through fluorescence microscopy of 
Nile red stained PHB (see Figure 2.9 D for SPION-PHB granules and Figure 2.10 D 
for AuNP-PHB granules).  Nile red exhibits little fluorescence in hydrophilic mediums 
yet brightly fluoresces upon incorporation into hydrophobic matrices.  The observation 
of Nile red-stained granules via fluorescence microscopy indicates that these 
nanoparticle-coated granules maintain a hydrophobic core as in native PHB granules.  
The resulting nanoparticle coating is consistent with the proposed mechanism of PHB 
granule formation and a possible assembly mechanism based on PHB granule 
formation is diagramed in Figure 2.11.  
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Figure 2.9: SPION-coated PHB granules 
PHB polymerization from SPION-PHA synthase conjugates produced SPION-coated 
PHB granules.  TEM analysis of polymerized material revealed SPION-coated PHB 
granules (Images A, B, and C) of various sizes with diameters of up to 1.5 µm.  Image 
D shows a micrograph of Nile red-stained SPION-coated PHB granules imaged via 
fluorescence microscopy and indicate that the AuNP-coated granules maintain a 
hydrophobic core as in native PHB granules.  
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Figure 2.10: AuNP-coated PHB granules 
PHB polymerization from AuNP-PHA synthase conjugates produced AuNP-coated 
PHB granules.  TEM analysis of polymerized material revealed AuNP-coated PHB 
granules (Images A, B, and C) of various sizes with diameters of up to 1.5 µm.  Image 
D show a micrograph of Nile red-stained AuNP-coated PHB granules imaged via 
fluorescence microscopy and indicate that the AuNP-coated granules maintain a 
hydrophobic core as in native PHB granules.  
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Figure 2.11: Proposed mechanism for nanoparticle-coated PHB granule 
formation 
From PHA synthase-conjugated nanoparticles (I) PHB polymer chains may form (II) 
and PHB chains then begin to aggregate via hydrophobic interactions between PHB 
leading to the formation of PHB granules with nanoparticles remaining on their 
surface (III).  
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2.5. Conclusions 
In this work, ~45 nm nanoparticle-PHA synthase conjugates were constructed 
with the capability of polymerizing PHB.  PHB polymerization from these conjugates 
resulted in nanoparticle-coated PHB granules offering a new means for producing 
functionalized PHB particles.  The resulting nanoparticle coating of PHB granules is 
consistent with the native in vitro-polymerized PHB granule structure in which PHA 
synthase remains on the granule surface.  In an analogous manner to the formation of 
native PHB granules, PHB granule formation from nanoparticle-PHA synthase 
conjugates is likely derived from the polymerization of PHB from PHA synthase on 
the surface of nanoparticle-conjugates leading to the coalescence of PHB chains via 
hydrophobic interactions.  The coalescence of polymerizing nanoparticle-conjugates 
leads to the formation of PHB granules with nanoparticles remaining on their surface.   
A wide range of biomolecules have been immobilized on the surface of PHB 
granules that have allowed for using functionalized granules in applications ranging 
from protein purification(42, 105) to cancer cell targeting(44, 52).  Of the PHB 
granule functionalization strategies employed to date, only one approach has allowed 
for coating PHB granules with inorganic materials(45).  In these studies, Escherichia 
coli was made to express PHA synthase fused to gold- and silica-binding peptides.  
The formation of PHB granule inclusions within the Escherichia coli resulted in self-
assembly of PHB granules displaying binding sites for gold or silica.  These beads 
could then be decorated with gold or silica nanoparticles after extraction of the in vivo-
produced granules from Escherichia coli.   
In contrast to in vivo granule formation, our in vitro approach allows for the 
direct assembly of nanoparticle-coated PHB granules in a single-step process.  
Furthermore, in vitro granule formation may allow for straight-forward means of 
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controlling PHB granule size(52, 106).  In contrast, in vivo approaches for PHB 
granule size control require regulation of GAP expression within the host organism – a 
feat that has not yet been demonstrated(15).  On the other hand, alternative approaches 
to nanoparticle coating of PHB granules may be achieved via decoration of 
synthetically produced PHB particles with nanoparticles conjugated to GAPs other 
than PHA synthase.  Such approaches may allow for a greater degree for size control 
as has been demonstrated for synthetic PHB particle production(27).  Yet, while PHB 
granules with diameters of less than 1 micron may be readily produced via 
biosynthetic means(52, 106), only one synthetic approach (i.e. that does not employ 
PHA synthase) has demonstrated the production of nano-sized PHB particles with the 
majority of synthetic approaches resulting in PHB particles with diameters that are 
greater than 1 micron (Table 1.2).  
The arrangement of nanoparticles on the PHB granule surface may result in 
nanoparticle-aggregation-based phenomena that may be applicable in biomedical 
applications.  The following chapters explore the possible MRI-based applications of 
SPIO-coated PHB granules and the spectroscopic-based applications of AuNP-coated 
PHB granules.  
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Chapter 3 – Superparamagnetic iron oxide nanoparticle-coated PHB granules   
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3.1.  Abstract 
Polyhydroxyalkanoate (PHA) synthase attached to superparamagnetic iron 
oxide nanoparticles (SPION) produce poly(3-hydroxybutyrate) (PHB) upon the 
addition of 3-hydroxybutyrate-CoA, and then coalesce to form nano- to micron-sized 
SPION-coated PHB granules. The SPION-coated PHB granules that are potential MRI 
contrast agents with enhanced imaging capabilities afforded by PHB mediated 
aggregation of SPION that resulted in SPION-coated PHB that exhibited ~2-fold 
improvement in T2 relaxivity (168 s-1 mmol-1 Fe) when compared to free SPION 
conjugated to PHA synthase (87.5 s-1 mmol-1 Fe).  Control of PHB granule size is also 
demonstrated via the addition of the surfactant Tween 20 allowing for producing PHB 
granules down to 100 nm in diameter.  In addition, SPION-PHA synthase are shown 
to allow for controlled retention of SPION within porous matrices via PHB 
polymerization where in situ polymerization of PHB from SPION-PHA synthase 
within agarose gel was shown retain up to 4.2-times greater amount of SPION when 
compared to SPION-PHA synthase samples that did not undergo polymerization.  The 
SPION-PHA synthase conjugates described herein could find use as advanced contrast 
agents with a high degree of control for their biodistribution based on the tuning of 
their size and the capability for their localized retention in porous matrices. 
3.2.  Introduction 
Superparamagnetic iron oxide nanoparticles (SPION) are widely used in 
biomedical imaging as MRI contrast agents due to their localized shortening of spin-
spin (T2) proton relaxation times(75, 76, 107).  Early studies of SPION-based contrast 
agents found applicability in imaging of the liver, spleen, and bone marrow due to 
their sequestration by cells of the reticuloendothelial system (RES) (108-111).  The 
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applicability of these initial SPION contrast agents was limited due to rapid liver 
uptake and short blood half-life.  More recent developments modifying the 
physicochemical properties of SPION materials have allowed for expansion of their 
biodistribution, pharmacokinetics, and contrast properties(112-114).  Nevertheless, 
most applications of SPION contrast agents have relied on the passive distribution that 
results from the physicochemical properties of the particles.  Approaches that aim to 
instead actively control SPION biodistribution have primarily involved antigen 
targeting via antibodies conjugated to SPION.  In addition, a recently reported 
alternative approach involved SPION retention in the articular cavity by external 
magnetic field(115). 
Recent trends in SPION-based contrast agent development have involved 
nanoparticle aggregation-based approaches that have revealed further enhancements in 
their MRI contrast properties(116-119).  The local T2 proton relaxivity of SPIO 
nanoparticles can be modified through aggregation of the SPION providing control of 
the ultimate nanoparticle aggregate size and magnetic properties with the end goal of 
their optimization for specific imaging applications(116-118, 120).  Aggregation of 
superparamagnetic materials affects their transverse relaxivity by manipulating the 
magnetic field gradients through which water diffuses(116) and SPIO nanoparticle 
aggregates have been recently studied as MRI contrast agents as agents with enhanced 
properties for T2-weighted MRI(119, 120). 
In this study, the effects of PHB-mediated aggregation of SPION from SPION-
PHA synthase conjugates were examined by comparing the T2 relaxivity of SPION-
coated PHB to that of SPION-PHA synthase conjugates prior polymerization.  In 
addition, the ability to control SPION-PHB granule size is examined and the ability to 
control SPION retention within porous matrices is demonstrated through in situ 
polymerization of PHB within agarose gel. 
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3.3.  Experimental 
3.3.1. Controlled SPION retention 
Agarose gel matrices with pore sizes of ~150 nm and ~400 nm were prepared 
casting the gel in square plastic dishes with a gel comb embedded in the agarose 
solution.  Agarose solutions were prepared following Narayanan, et al.(121); briefly, 
high melt agarose powder (IBI Agarose, Shelton Scientific, Inc, Shelton, CT) was 
dissolved in deionized water at 0.75% and 2% (w/v) agarose concentrations and 
heated in an incubator oven for 30 min at 110 °C.  The solutions were then stirred and 
sonicated for one hour and held in the oven for an additional 30 min.  The hot 
solutions were then poured into the casting apparatus and were allowed to set while 
incubating at 35 °C.  Based on this procedure, the gel pore sizes were expected to be 
in the order of 150 nm for 2% (w/v) agarose and 400 nm for 0.75% (w/v) 
agarose(121).   
After the gels had solidified, the comb was removed and 5 uL of SPION-PHA 
synthase samples at OD500 = 0.25 were added to wells in the gel.  The SPION-PHA 
synthase was then drawn into the gel by placing a magnet beneath the gel cast and 
placing the sample at 4 °C for 18 hrs.  Next, 2 µL of 50 mM 3HB-CoA or water was 
added the wells allowed to incubate for 12 hrs at room temperature. Samples with and 
without substrate were prepared in triplicate.  After incubation, the wells were excised 
from the bulk of the agarose gel by cutting out 1 cm2 portions of gel from the top, each 
containing a well at the center of the 1 cm2 area.  Gel samples were then placed 
upright and photographed from the side with a digital camera.  The gel samples were 
then submerged in 50 mM phosphate buffer, pH 7 within sealed containers and were 
placed on a rocking table at room temperature.  At hourly intervals, the samples were: 
removed from the containers, photographed, replaced in the containers with fresh 
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buffer, and left to rock again.  Photographs were then analyzed via densitometry using 
Image J gel analysis software. 
3.3.2. T2 measurements and analysis 
T2 measurements were conducted via collaborative efforts with Richard 
Wong, PhD Candidate in Professor Yi Wang’s laboratory, at the Cornell University 
MRI Laboratory Group, Weill Medical College, New York, NY.  PCR tubes (250 µL) 
were filled with serial dilutions of SPION-PHA synthase at Fe concentrations ranging 
from 0.00-0.33 mM having undergone and not undergone polymerization.  Imaging 
was conducted at 3 Tesla (GE Signa Excite, GE Healthcare, Uppsala, Sweden) and the 
imaging protocol consisted of a T2-weighted spin-echo sequence (TR 3000 ms, 
variable TE: 14, 25, 50, 75, 100, 150, 200, 250, 300 ms, 9 individual scans).  The slice 
thickness was 5 mm with a field of view (FOV) of 8 cm, Frequency x Phase of 256 x 
256, Phase FOV of 0.5, and 1 number of excitations (NEX).  The MR images obtained 
at various echo times (TE’s) were cropped to the contents of the PCR tubes and 
processed to obtain R2 (1/T2) maps and the experiment was repeated four times.  
Figure 3.1 shows a representative MRI image from which T2 analysis was conducted. 
Determination of iron concentration of SPION samples was conducted by third 
party services provided by M.A. Rutzke, PhD, Cornell University, Department of 
Food Science, Ithaca, NY(122-125).  Briefly, samples were digested with concentrated 
nitric acid at 120 °C until dry followed by a 50/50 mixture of concentrated nitric acid 
and perchloric acid that was heated at 220 °C until again dry.  After cooling, the 
resulting ash was dissolved with concentrated HCl, diluted with 5% HNO3 and 
analyzed with an axially viewed inductively coupled plasma (ICP) trace analyzer 
emission spectrometer (ICAP 61E trace analyzer, Thermo Electron, Waltham, Ma) 
with the replacement of the transfer optics with a short depth of field transfer optics to 
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reduce matrix effects.  With these measurements, an OD vs Fe molarity plot was 
obtained and used to determine the Fe molar concentration via OD measurements.  
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Figure 3.1: MRI analysis of SPION-PHA synthase before vs. after polymerization 
The T2 relaxivity of SPION-PHA synthase and SPION-coated PHB was derived by 
MRI analysis of serial dilutions of each of the materials.  PCR tubes were filled with 
serial dilutions of SPION-PHA synthase (top row) and SPION-PHA synthase with the 
addition of 3HB-CoA (bottom row).  The tubes were then imaged via MRI using an 
imaging protocol that consisted of a T2-weighted spin-echo sequence.  The figure 
shows that T2 (1/R2) decrease more rapidly with increasing Fe concentration for 
SPION-coated PHB granules vs. SPION-PHA synthase conjugates thus exhibiting an 
improvement in T2 relaxivity of SPION-coated PHB granules over SPION-PHA 
synthase.  
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3.3.3. PHB granule size control 
Samples of PHA synthase (0.1 mg/mL) were prepared with the addition of the 
surfactant polyoxyethylene sorbitan monolaurate (Tween 20) at concentrations of 0%, 
0.025%, 0.05%, 0.1% v/v (Tween 20 Enzyme Grade, Thermo Fisher Scientific, 
Rockford, IL).  2.5 mM of 3HB-CoA was then added to each sample and PHB granule 
growth was monitored via DLS (Malvern Zetasizer Nano, Malvern Instruments, 
Worcestershire, United Kingdom) at 25 °C.  To examine the effect of Tween 20 on 
SPION-PHB granule formation, samples of 0.1 mg/mL SPION-PHA synthase (based 
on protein concentration) were prepared with the addition of Tween 20 at 0%, 0.025%, 
and 0.1% v/v and the subsequent addition of 5 mM 3HB-CoA.  Samples were then 
imaged via TEM after 1 hr of incubation at room temperature. 
3.4.Results and Discussion 
3.4.1. PHB-mediated controlled SPION retention 
In order to examine the potential for controlled retention of SPIO in porous 
matrices, SPION-PHA synthase conjugates were magnetically driven into 2% and 
0.75% agarose gel matrices corresponding to ~150 nm and ~400 nm-diameter pore 
sizes, respectively, and representing a range of possible tissue pore dimensions(121).  
After 156 hrs, samples subjected to in situ polymerization within the gel resulted in 
3.6-times greater retention of SPION in 2% agarose and 4.2-times greater retention in 
0.75% agarose when compared to un-polymerized SPION-PHA synthase.  A biphasic 
release of SPION was observed with a more rapid release of SPION over the first 40 
hrs and 60 hrs for 2% (Figure 3.2) and 0.75% (Figure 3.3) agarose, respectively, 
followed by a slower rate of release.  Two phase exponential decay fits of the data 
revealed that the half-life of the earlier and later decays were 1.5 and 1.2-fold longer, 
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respectively, for samples that had undergone polymerization in 0.75% agarose and 1.9 
and 1.5-fold longer, respectively, for samples that had undergone polymerization in 
2% agarose.  The observed biphasic release profile may be due to an initial more rapid 
release of SPION not associated with PHB followed by a slower release of aggregated 
particles. 
This PHB-mediated controlled retention of SPION in porous matrices may 
allow for site-specific sustained dosage of SPION in tissue systems.  SPION-PHA 
synthase, which are 50 nm in diameter (Figure 2.8), may be able to penetrate into 
biological tissues with pores of suitable dimensions and then SPION could be 
entrapped in the tissue via in situ polymerization within the tissue.  This mechanism 
might be suitable for application within capillaries that possess holes or 'fenestrae' 
(~50-100 nm diameter) predominantly on their venous limbs or in the interstitial tissue 
where the mean diameters of pores in the muscle and intestine are on the order of 60-
120 nm(126). 
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Figure 3.2: In situ PHB polymerization-mediated SPION retention in 0.75% 
agarose 
SPION-PHA synthase conjugates were magnetically driven into 0.75% agarose gel 
corresponding to ~400 nm-diameter pore size and the subsequent diffusion of SPION 
out of the gel was examined via densitometry of gel images.  A biphasic release of 
SPION was observed when comparing the optical density of samples having 
undergone in situ polymerization of PHB within the gel (red) to that of samples that 
did not undergo polymerization (black) and two phase exponential decay fits of the 
data during the later phase of release were used to determine and compare SPION 
retention and rates of release.  The half-life of the earlier and later decays were 1.5 
and 1.2-fold longer, respectively, for samples that had undergone polymerization and 
after 156 hrs, samples subjected to in situ polymerization within the gel resulted in 
4.2-times greater retention when compared to un-polymerized SPION-PHA synthase.  
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Figure 3.3: In situ PHB polymerization-mediated SPION retention in 2% agarose 
SPION-PHA synthase conjugates were magnetically driven into 2% agarose gel 
corresponding to ~150 nm-diameter pore size and the subsequent diffusion of SPION 
out of the gel was examined via densitometry of gel images.  A biphasic release of 
SPION was observed when comparing the optical density of samples having 
undergone in situ polymerization of PHB within the gel (red) to that of samples that 
did not undergo polymerization (black) and two phase exponential decay fits of the 
data during the later phase of release were used to determine and compare SPION 
retention and rates of release.  The half-life of the earlier and later decays were 1.9 
and 1.5-fold longer, respectively, for samples that had undergone polymerization and 
after 156 hrs, samples subjected to in situ polymerization within the gel resulted in 
3.6-times greater retention when compared to un-polymerized SPION-PHA synthase. 
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Figure 3.4: Relaxivity of SPION-PHA synthase before vs. after polymerization 
Based on MRI measurements as depicted in Figure 3.1, R2 (1/T2) values at varying 
SPION-PHA synthase concentrations with (red) and without (black) the addition of 
3HB-CoA were used to plot R2 values vs. iron concentration from four different sets of 
experiments.  The lines on the plot are the averages of linear fits of the data for each 
experiment and whose slopes were used to determine the T2 relaxivity of each 
material.  SPION-coated PHB granules exhibited 1.92 ± 0.178-fold higher T2 
relaxivity than SPION-PHA synthase.   
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3.4.2. Enhanced T2 relaxivity of SPION-coated PHB granules 
The T2 relaxivity of SPION-PHA Synthase were analyzed with and without 
PHB polymerization (Figure 3.4).  Increasing concentrations of nanoparticles were 
imaged via MRI (Figure 3.1) in order to calculate R2 maps.  Figure 3.4 shows the R2 
(1/T2) values plotted versus iron concentration. 
The relaxivity was determined from linear fits of the data and resulted in 168 ± 
29.1 s-1 mmol-1 Fe for polymerized samples vs. 87.5 ± 3.49 s-1 mmol-1 Fe for SPION-
PHA synthase without polymerization, comparing favorably with FDA approved 
SPIO-based contrast agents among which the highest relaxivity is 160 s-1 mmol-1 (127).  
The SPION-coated PHB thus exhibited a 1.92 ± 0.178-fold improvement in T2 
relaxivity when compared to SPION-PHA synthase. 
Contrast enhancement due to SPION aggregation has been extensively studied 
in the context of compact clusters(116-118, 120) and it has been shown that compact 
clusters of SPION induce relaxation equivalent to similarly sized single particles(128).  
The SPION-PHB granules form a SPION-shell rather than compact clusters and while 
several studies have described similar structures(129-132), none have examined the 
specific effects of a magnetic shell structure on T2 relaxivity.  Nevertheless, similar 
shell structures have been found to exhibit a single dipole with behavior similar to 
single larger magnetic particles when exposed to external magnetic fields(132).  
Interestingly, magnetic shell structures composed of SPION have also been shown to 
deform under external magnetic fields(129).  If this phenomenon is also exhibited by 
SPION-PHB granules, this may allow for controlled release of encapsulated material 
within the PHB core thereby providing a means for magnetically-triggered drug 
delivery. 
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3.4.3. Size control 
The addition the surfactant Tween 20 allowed for controlling PHB granule size 
(Figure 3.5).  When analyzing the granule size vs. Tween 20 concentration, increasing 
the Tween 20 concentration during polymerization resulted in decreased granule size 
following a first order exponential decay (R2 = 0.997) (Figure 3.6).  Under the 
conditions of the experiment, the PHB granule diameter could thus be controlled down 
to ~100 nm.  Based on these results, SPION-PHA synthase samples were incubated 
with 3HB-CoA and increasing amounts of Tween 20 in order to generate SPION-
coated PHB granules of varying sizes.  Similarly, a decreasing SPION-coated PHB 
granule size was observed (Figure 3.9) with increasing Tween 20 concentrations. 
The mechanism by which Tween 20 is able to regulate PHB granule size is 
likely to be analogous to that of the GAP phasin.  Phasins are amphiphilic proteins that 
serve to stabilize the granules and prevent their coalescence as well as the nonspecific 
binding to their milieu(54).  Their hydrophobic region associates with the outer 
surface of the growing PHB granule thus reducing the available sites for additional the 
binding of PHA synthase and restricting the granule’s growth.  Phasins have been 
shown to influence granule size both in vivo and in vitro(106, 133-136).  
Overproduction of PhaP leads to the formation of many small granules(137) in vivo 
and, conversely, strains unable to produce any phasin protein accumulate only one 
single large PHA granule(138). 
Control of particle size is an important aspect of nanoparticle development for 
in vivo applications(139) yet thus far only one aggregation-based methodology for 
SPION contrast agent optimization has demonstrated(118).  Separately, the majority 
of studies involving PHB particle size control have been conducted with solvent-based 
methodologies for PHB particle synthesis(27, 57) and of these, only one study 
describes a method for the synthesis of sub-micron diameter PHB particles(57).  On 
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the other hand, while in vivo produced PHB granules are typically sub-micron due to 
size restrictions of the host organism, size control of in vivo-produced granules has not 
yet been characterized(15).  Nevertheless, methodologies for size control of in vitro 
enzyme-produced granules have been described where the addition of phasins, the 
GAP GA24 of R. eutrophus, and BSA have been shown to reduce PHB granule 
size(106).  Another approach for in vitro biosynthesized PHB granule size control has 
been achieved via modulation of the substrate:enzyme ratio(52).  The results in this 
study demonstrate that the surfactant Tween 20 offers an additional avenue for 
biosynthetic PHB granule size control and is the first such example that does not 
require the use of GAPs for controlling granule size.  
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Figure 3.5: PHB granule size control 
The growth of PHB granules in the presence of various amounts of Tween 20 (% v/v) 
was monitored via DLS.  PHA synthase and 3HB-CoA were mixed at time zero and in 
the presence of increasing amounts of Tween 20 then the mixture was analyzed via 
DLS over time.  The data was fit to first order exponential decays all of which 
exhibited an R2 > 0.99 and it was observed that increasing the Tween 20 
concentration resulted in a decrease in PHB granule size.  
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Figure 3.6: PHB granule size vs. Tween 20 concentration 
In order to determine the relationship between Tween 20 concentration and steady-
state PHB granule size, the asymptotes from each exponential decay fit shown in 
Figure 3.5 were plotted vs. Tween 20 concentration.  Increasing the Tween 20 
concentration during PHB polymerization resulted in decreasing PHB granule size 
following a first order exponential decay in PHB granule diameter vs. Tween 20 
concentration (R2 = 0.99744) with a minimum granule diameter approaching 100 nm 
at concentrations of Tween 20 greater than 0.10% (v/v).  The mechanism underlying 
this observed relationship is likely analogous to that of the amphiphilic GAP phasin 
that serves to stabilize in vivo-produced granules via the association of their 
hydrophobic region with the outer surface of PHB granules thus reducing the 
available sites for additional the binding of PHA synthase and restricting the 
granule’s growth.  
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Figure 3.7: SPION-coated PHB granule size control  
SPION-coated PHB granules were grown to various sizes by varying the 
concentration of Tween 20 present during PHB polymerization.  SPION-PHA 
synthase conjugates were mixed with 3HB-CoA in the presence of Tween 20 at 0, 
0.025, and 0.1% (v/v).  The figure shows TEM images SPION-coated PHB granules 
formed in the presence of the varying concentrations of Tween 20.  SPION-coated 
PHB granules of decreasing diameter were observed with increasing Tween 20 
concentrations.  
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3.5.Conclusions 
In situ PHB polymerization from SPION-PHA synthase conjugates within 
agarose gel resulted in increased SPION retention within the gel when compared to 
un-polymerized SPION-PHA synthase.  This PHB-mediated controlled retention of 
SPION in porous matrices may allow for site-specific sustained dosage of SPION in 
tissue systems.  When compared to SPION-PHA synthase, SPION-coated PHB 
granules exhibited enhanced T2 relaxivity properties reaching 168 s-1 mmol-1, 
comparing favorably with FDA approved SPIO-based contrast agents among which 
the highest relaxivity is 160 s-1 mmol-1 (127).  Finally, the addition of Tween 20 during 
in vitro PHB polymerization resulted in a decrease in PHB granule diameter allowing 
for control of the granule size. 
Thus far only one aggregation-based methodology for SPION contrast agent 
size control has demonstrated(118).  In addition, few studies have investigated means 
of controlling the size of in vitro-produced biosynthetic PHB granules(52, 106).  
While the studies described in this chapter offer an additional means of controlling 
SPION-aggregate and PHB granule size, this system requires further characterization 
in order to determine aspects such as the size polydispersity of the resulting PHB 
granules.  The surfactant-based size control methodology described herein deviates 
from the more ‘bio-friendly’ biomolecule-based reaction conditions that differentiate 
biosynthetic means of PHB granule production from synthetic means that employ 
organic solvents, nevertheless, Tween 20 is known to be nontoxic and is employed in 
the food processing and pharmaceutical industries(140).  Furthermore, the use of 
Tween 20 as opposed to GAPs for controlling PHB granule size is advantageous given 
that the surfactant is commercially available. 
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Aggregation-based methodologies for the development of SPION-based 
enhanced contrast agents have shown promise in broadening the applicability of such 
materials(116-120) and the PHB polymerization-mediated aggregation capabilities 
described herein may allow for optimization of the SPION-PHB granules in specific 
imaging applications.  In situ polymerization of locally injected SPION-PHA synthase 
and the size-control of SPION-coated PHB granules for use in systemic administration 
could offer two separate avenues for controlling biodistribution and clearance based 
on PHB polymerization-mediated SPION aggregation.  With regard to in situ 
polymerization-mediated SPION retention, an advantage of this system when 
compared to SPION retention from the application of localized magnetic fields(115) is 
that there is no need for equipment that would need to be constantly applied for 
causing SPION retention.  On the other hand, while it may be feasible to systemically 
administer SPION and cause their site-specific accumulation via external magnetic 
field, our polymerization-mediated retention approach may be limited to simultaneous 
local injection of SPION-PHA synthase and 3HB-CoA since the substrate would need 
to be applied locally and would quickly diffuse from the injection site.   
With regard to size-control of SPION-coated PHB granules for systemic 
administration, a particular advantage of SPION-coated PHB granules may lie in the 
nanoparticle coating.  PEGylated particles have generally resulted in longer circulation 
times due to their prevention of nonspecific interactions with proteins through the 
hydrophilicity and steric repulsion effects provided by PEG resulting in reduced 
opsonization and complement activation(141-144).  Nevertheless, smaller PEGylated 
nanoparticles (< 100 nm) have been shown to have longer clearance than larger 
PEGylated nanoparticles (100 nm < x < 500 nm); an effect that has been attributed to 
increased PEG packing density on smaller nanoparticles(144, 145).  In light of these 
observations, since SPION-coated PHB granules are coated with individually 
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PEGylated ~45 nm SPION, the PEG packing density that coats PHB granules is 
expected to stay constant with varying PHB granule size.  This effect may hold an 
advantage when compared to other PEGylated particles of varying sizes in that the 
prevention of opsonization may facilitate hepatocyte-mediated rather than Kupffer 
cell-mediated clearance of the grnaules(146).  In this case, the granules would follow a 
more direct elimination route via excretion into the bile rather than sequestration 
within Kupffer cells that retain foreign materials until it can be eliminated via 
intracellular degradation.  
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Chapter 4 – Gold nanoparticle-coated PHB granules  
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4.1.  Abstract 
Polyhydroxyalkanoate (PHA) synthase attached to gold nanoparticles (AuNP) 
produce poly(3-hydroxybutyrate) (PHB) upon the addition of 3-hydroxybutyrate-CoA, 
and then coalesce to form nano- to micron-sized AuNP-coated PHB granules.  These 
AuNP-coated PHB granules are potential theranostic agents that have enhanced 
imaging capabilities and are also capable of heating upon near-infrared (NIR) laser 
irradiation.  The AuNP-coated PHB exhibited 11-fold enhancement in surface-
enhanced Raman scattering over particles prior polymerization.  Stained AuNP-coated 
PHB exhibited a 6-fold enhancement in fluorescence intensity as well as a 1.3-fold 
decrease in photobleaching rate when compared to PHB granules alone.  The granules 
were also shown to emit heat when illuminated at 808 nm with a 3.9-fold increase in 
heating rate when compared to AuNP-PHA synthase alone.  In addition, NIR laser 
illumination of fluorescent doxorubicin-loaded AuNP-PHB granules resulted in loss of 
fluorescence possibly due to destruction of the PHB granule structure, providing a 
potential means of burst drug delivery from AuNP-PHB granules. 
4.2.  Introduction 
Gold nanoparticles have been employed in a variety of diagnostic and 
therapeutic applications.  Radioactive conjugates of colloidal gold have been used in 
the treatment of human cancers since the 1940s(147) where systemic administration of 
colloidal ‘radiogold’ was first used in the treatment of leukemias and lymphomas.  
These particles were naturally taken up by the RES cells in the liver, the spleen, and 
the bone marrow(147, 148) and their toxicity was attributed to radiation effects and 
not to the gold particles(147, 148).  In more recent studies, RES clearance of gold 
particles has been shown to be mediated via uptake by Kupffer cells in the liver(149, 
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150).  Long-term safety data and observed clearance routes make gold nanoparticles a 
good candidate for in vivo diagnostic and therapeutic applications(151). 
4.2.1. SERS-based applications 
The surface plasmon resonance of AuNPs is sensitive to the surrounding 
environment of the particle and is strongly dependent on the proximity to other 
particles(152).  Due to significant enhancements of Raman signal strengths from the 
molecules in the vicinity of the surface plasmon resonance (SPR) of gold 
nanostructures, gold nanoparticles have been applied as surface enhanced Raman 
scattering (SERS)-based ‘nanosensors’ for local chemical probing of native biological 
molecules inside living cells(153-160).  SERS provides structure-specific vibrational 
spectra of analytes with extremely high sensitivity resulting in many advantages over 
predominant fluorescence-based techniques.  When compared to NIR-emitting 
quantum dots, in vivo mouse studies targeting tumor cells using SERS probes have 
resulted in two orders of magnitude brighter signal with broader multiplexing 
capabilities(161, 162). 
4.2.2. Enhanced fluorescence applications 
Enhanced fluorescence due to interactions between an excited fluorophore and 
plasmons of noble metal nanoparticles increase the quantum yield and photostability 
of the fluorophore(85-88).  Silver nanoparticles conjugated to fluorophores have been 
employed in live cell studies where cell images were monitored via emission intensity 
and fluorophore lifetime(163-165).  In these studies, emission signals from the metal 
probes could be isolated and counted on the cell images allowing for the quantification 
of target molecules on the cell surface at the single cell level.  Other enhanced 
fluorescence applications have included their use in immunoassays where up to 66-
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fold improvements in limits of detection have been reported when compared to their 
conventional counterparts(166-171). 
4.2.3. Photothermal applications 
Photothermal applications gold nanoparticles are currently undergoing clinical 
trials(172-174).  Systemically administered of AuNPs have been shown to accumulate 
in tumors, where they have been irradiated with NIR laser light causing heating of the 
tumor tissue.  Healthy tissue without associated nanoparticles is unaffected by the NIR 
laser light since at these wavelengths (600-1100 nm), there is lack of efficient 
endogenous absorbers allowing for high light penetration depth and decreased laser 
damage to non-target tissue(96, 97).  On the hand, cancer cells in close proximity to 
AuNPs undergo hyperthermia and death, resulting in tumor remission(172, 175, 176). 
4.2.4. Drug delivery 
The interactions between photons and AuNP may allow for an additional 
therapeutic modality in AuNP-PHB granules in which drug release from drug-loaded 
granules could be triggered via local heating of AuNP on the PHB granule surface.  
Light-triggered release of substances from hydrogels has been previously described 
where light-induced structural changes such as contraction of the hydrogel causes the 
release of preloaded substances within the gel(177).  The possibility for AuNP-
mediated structural changes to PHB granules may allow for applying this unique 
means of delivery to the AuNP-PHB system. 
 
Here we describe the aggregation-mediated plasmon-induced properties of 
AuNP-coated PHB granules.  AuNP-coated PHB granules are shown to exhibit 
enhanced SERS and fluorescence as well as the capability of emitting heat from NIR 
illumination.  These properties may allow for the use of these granules as theranostic 
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agents that may be followed via SERS and fluorescence and may deliver therapeutic 
payloads in the form of heat and as a PHB-mediated drug-delivery agent(51, 52, 178, 
179). 
4.3. Experimental 
4.3.1. Raman spectroscopy 
SERS analysis was performed using a Renishaw InVia microRaman system 
(Renishaw Plc, Gloucestershire, United Kingdom) equipped with a 785 nm solid-state 
laser.  Three different compounds for Raman reporting including phenyl disulfide, 
benzyl disulfide, and 2-mercaptopyridine (all purchased from Sigma Aldrich, St. 
Louis, MO) were prepared at 1 mM in 50 mM sodium phosphate buffer, pH 7.  To test 
the molecular specificity of the functionalized nanoparticles, as-synthesized gold 
particles coated with oleic-acid/oleylamine, functionalized gold particles coated with 
PL-PEG-COOH, and 5 nm citrate-stabilized gold particles (Product # G1402, Lot # 
026K6112, Sigma Aldrich, St. Louis, MO) were used to prepare films of gold 
nanoparticle aggregates by drying 5 µL of particle solutions (optical density at 520 nm 
of 0.08) on a silicon substrate.  Five microliters of each of the Raman reporter 
molecule solutions were then added to separate dried preparations of each of the 
nanoparticle samples and were then allowed to dry before scanning with the Raman 
spectrometer between 600 and 2000 cm-1 at 10% laser power with a 10 second 
exposure time.  Raman data was processed by first subtracting the Raman spectra of 
the silicon background and then subtracting an end-weighted baseline using OriginPro 
7.5 graphing software (OriginLab Corporation, Northampton, MA). 
To measure the effect of PHB polymerization from AuNP-PHA synthase 
conjugates on SERS activity, a sample of AuNP-PHA synthase at an optical density at 
520 nm of 0.08 was divided into two equal aliquots.  3HB-CoA was added to one 
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aliquot at a final concentration of 2.5 mM with the other aliquot diluted accordingly 
with water.  The samples were allowed to stand at room temperature for two hours 
then a solution of phenyl disulfide in 50 mM sodium phosphate buffer, pH 7 was 
added to each sample at a final phenyl disulfide concentration of 1 mM.  These 
solutions were then diluted 1/2, 1/5, and 1/10-fold and 5 µL of each of the dilutions 
were dried on a silicon substrate before scanning with the Raman spectrometer 
between 975 and 1125 cm-1 at 10% laser power with a 10 second exposure time.  Five 
measurements were taken for each sample and the data was processed by first 
subtracting the Raman spectra of the silicon background and then subtracting an end-
weighted baseline using OriginPro 7.5 graphing software (OriginLab Corporation, 
Northampton, MA). 
4.3.2. Fluorescence measurements and analysis 
The nanoparticle absorption spectra where acquired using a Shimadzu Mpc-
3100 UV-VIS-NIR Scanning Spectrophotometer (Shimadzu Corporation, Kyoto, 
Japan).  Fluorescence spectra were obtained using a Perkin Elmer LS-50B 
Luminescence Spectrometer (Perkin Elmer, Waltham, MA).  To analyze AuNP-
caused quenching of Nile red, samples with and without AuNP-PHA synthase and 
containing 1 µg/mL of Nile red and 0.1 mg/mL of PL-PEG-COOH were compared.  
Since Nile red only exhibits appreciable fluorescence when in hydrophobic 
environments, PL-PEG-COOH was included in these samples in order to measure Nile 
red fluorescence in samples prior to the addition of AuNP-PHA synthase.  PL-PEG-
COOH forms micelles in the aqueous solution and upon the addition of AuNP-PHA 
synthase (final OD520 = 0.025), Nile red equilibrates its distribution between PL-PEG-
COOH micelles and the hydrophobic layer in AuNP-PHA synthase.  For both 
absorption and fluoresce measurements, samples were placed in 3 mm path length 
special optical glass fluorometer cells (Starna Cells, Inc. Atascadero, CA). 
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For enhanced fluorescence and photobleaching experiments, AuNP-coated 
PHB granules were prepared by mixing AuNP-PHA synthase (0.1 mg/mL based on 
protein concentration) with 3HB-CoA (5 mM) in 50 mM phosphate buffer, pH 7 and 
allowed to incubate at room temperature for 2 hrs.  Uncoated PHB granules were 
prepared by mixing PHA synthase (0.1 mg/mL) with 3HB-CoA (5 mM) in 50 mM 
phosphate buffer, pH 7 and allowed to incubate at room temperature for 2 hrs.  
Samples were then stained with Nile red at a 1 µg/mL working concentration.  
Fluorescence measurements were conducted with an inverted fluorescence microscope 
(Model IX51, Olympus Corporation, Tokyo, Japan), equipped with a 560 nm/645 nm 
excitation/emission filter cube (Chroma Technology Inc, Bellows Falls, VT), a 100X 
Olympus objective lens, and an Olympus DP70 CCD camera.  Images were captured 
at 1 second intervals for 30 sec using Image Pro Plus (Media Cybernetics, Inc, 
Bethesda, MD).  Image analysis was performed with Image Pro Plus by first setting a 
fixed threshold across all images based on the software’s edge detection algorithm that 
delineated individual fluorescent spots, then analyzing the diameter and intensity of 
individual fluorescent spots with a roundness value of 1, defined as the following: 
roundness = perimeter2 / (4 π area); a roundness value of 1 indicates a perfect circle 
and as the value approaches infinity, it indicates the shape is a line segment.  This 
roundness value was chosen in order to only analyze individual PHB granules and to 
avoid aggregates.   246 granules were analyzed for each sample. 
4.3.3. Heating 
Heating experiments were conducted using a 1.2 watt, 808 nm continuous 
wave diode laser (SDL-2360-C, JDL Uniphase, Milpitas, CA) culminated to 0.5 mm 
diameter with temperature measurements conducted with a fiber optic temperature 
sensor (Reflex Signal Conditioner, Neoptix, Québec, Canada).  A sample of AuNP-
PHA synthase at an optical density at 520 nm of 0.9 was divided into two equal 
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aliquots.  3HB-CoA was added to one aliquot at a final concentration of 2.5 mM with 
the other aliquot diluted accordingly with water.  The samples were allowed to stand at 
room temperature for two hours and thirty microliters of AuNP-PHA synthase samples 
prior and after polymerization were placed inside PCR tubes with the temperature 
probe positioned away from incident laser light.  Samples were illuminated at 3 
W/mm2 and their temperature was monitored over a period of 2 min.  Measurements 
were conducted in triplicate and referenced to measurements on 50 mM sodium 
phosphate buffer, pH 7. 
4.3.4. Laser-triggered AuNP-PHB-based drug delivery 
Doxorubicin (Dox) (Sigma Aldrich, St. Louis, MO) was loaded into AuNP-
PHB granules by mixing AuNP-PHA synthase (0.1 mg/mL based on protein 
concentration) with Dox (5 µg/mL) in 50 mM phosphate buffer, pH 7.5, then 
subsequently adding 3HB-CoA (5 mM) and allowing the sample to incubate at room 
temperature for 2 hrs.  Control samples included Dox loaded PHB granules, prepared 
as described above but with PHA synthase (0.1 mg/mL) instead of AuNP-PHA 
synthase, and samples containing AuNP-PHA synthase and Dox but no 3HB-CoA (i.e. 
prior to polymerization of PHB).  The fluorescence intensity of the samples was then 
measured using a fluorometer (Perkin Elmer LS 50 B scanning fluorometer, Perkin 
Elmer, Waltham, MA) prior and after laser irradiation at 3 W/mm2 for 2 min (1.2 watt, 
808 nm continuous-wave diode laser culminated to a 0.5 mm diameter).  Subsequent 
fluorescence measurements were again preformed 10 min and 12 hrs after irradiation.  
Samples were prepared in triplicate. 
 76 
4.4. Results and discussion 
4.4.1. Selectivity of AuNP-PL-PEG-COOH towards non-polar SERS reporters 
Of the two non-polar molecules (phenyl disulfide, phenyl disulfide) and one 
polar molecule (2-mercaptopyridine) examined as possible Raman reporters, phenyl 
disulfide and benzyl disulfide but not for 2-mercaptopyridine exhibited SERS with 
AuNP-PL-PEG-COOH particles (Figure 4.1).  This specificity towards hydrophobic 
compounds is thought to result from the hydrophobic layer coating at the junction 
between oleic acid/oleylamine and phospholipid tails of PL-PEG-COOH that 
prevented access for polar compounds to the gold particle surface.  To test this, each 
of the Raman reporter molecules were added to dried nanoparticle suspensions of as-
synthesized gold particles coated with oleic-acid/oleylamine, functionalized gold 
particles coated with PL-PEG-COOH, and commercially available 5 nm citrate-
stabilized gold particles.  SERS spectra were observed from all of the Raman reporter 
molecules on as-synthesized oleic-acid/oleylamine and commercially available 5 nm 
citrate-stabilized gold particles while SERS spectra from PL-PEG-COOH particles 
was only observed from the hydrophobic benzyl disulfide and phenyl disulfide (Figure 
3.1, data shown for PL-PEG-COOH and citrate-stabilized particles with phenyl 
disulfide).  Given this data, it seems that all of the compounds are able to displace 
citrate and bind to the gold particle surface – thiols and disulfides readily bind to gold 
to give stable monolayers(180).  Similarly, all of the compounds have access to the as-
synthesized oleic acid/oleylamine gold particles, yet only the hydrophobic compounds 
are able to penetrate the oleic acid/oleylamine-phospholipid layer surrounding the PL-
PEG-COOH functionalized particles.  
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Figure 4.1: Selectivity of PEGylated phospholipid-coated AuNP for nonpolar 
Raman reporters 
Phenyl disulfide and 2-mercaptopyridine were mixed with AuNP-PL-PEG-COOH and 
citrate coated AuNP in order to determine the molecular specificity of the AuNP to 
these Raman reporters based on the different nanoparticle coatings.  AuNP-PL-PEG-
COOH particles (red trace) exhibited SERS for non-polar molecules such as phenyl 
disulfide (top) but not for polar molecules such as 2-mercaptopyridine (bottom).  
Citrate-stabilized gold particles (black trace) instead exhibited SERS activity for both 
polar and non-polar molecules.  Both polar and non-polar compounds are able to 
displace citrate and bind to the gold particle surface via thiol and disulfide groups in 
these compounds, yet only the hydrophobic compounds are able to penetrate the oleic 
acid/oleylamine-phospholipid layer surrounding the PL-PEG-COOH functionalized 
particles.  
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4.4.2. Surface Enhanced Raman Scattering 
AuNP-coated PHB granules exhibited enhanced SERS over AuNP-PHA 
synthase particles.  When comparing the 1000 cm-1 (benzene ring vibration(181)) 
Raman band intensity of phenyl disulfide on AuNP-PHA synthase and AuNP-coated 
PHB granules, at the lowest dilution (based on the OD520 of each sample) at which 
AuNP-PHA synthase produced an observable signal over background, signal derived 
from AuNP-coated PHB granules exhibited an average Raman intensity of 3983 
counts over background signal (Figure 4.2).  The average relative enhancement factor 
ranged from 3 ± 0.2 to 11 ± 0.81 across the dilutions tested with the highest 
enhancement observed at the lowest dilution where AuNP-PHA synthase produced an 
observable signal over baseline (Figure 4.3). 
It is thought that the organization of gold nanoparticles around PHB granules 
gives rise to the observed SERS enhancement effects.  AuNP-PHB samples contain 
both AuNP-coated PHB as well as AuNP not associated with PHB granules and in the 
Raman measurements, both AuNP-PHB and AuNP-PHA synthase were dried 
resulting in both samples containing aggregated AuNP due to drying.  Thus, the 
observed enhancement in SERS from AuNP-coated PHB was in reference to that of 
SERS from aggregated AuNP-PHA synthase.  This observation indicates that 
enhancement in SERS is mediated by PHB polymerization that results in an 
enhancement factor over that of AuNP aggregation caused by the drying of AuNP-
PHA synthase samples.  The interparticle interactions on the PHB granule surface are 
likely to produce electromagnetic ‘hot spots’ and this is thought to provide the 
dominant form of SERS enhancement(79, 80).  Furthermore, the shell structure that is 
formed by the nanoparticle coating may also contribute to the observed enhancement 
as similar metallic shell structures have been shown to increase both the effective 
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volume in which molecules are affected by the enhanced electric field and the Raman 
gain averaged over this volume(182).  
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Figure 4.2: Enhanced SERS from AuNP-PHA Synthase before vs. after 
polymerization 
Material containing AuNP-coated PHB granules exhibited enhanced SERS when 
compared to SERS derived from AuNP-PHA synthase conjugates.  The Raman spectra 
of phenyl disulfide added to AuNP-PHA synthase and AuNP-coated PHB granules 
was compared from samples diluted such that those containing AuNP-PHA synthase 
produced signal close to background.  Under these conditions, an equal amount of 
AuNP from samples containing AuNP-coated PHB granules exhibited an average 
Raman intensity of 3983 counts over background signal.  
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Figure 4.3: Raman limit of detection of phenyl disulfide on AuNP-PHA synthase 
before vs. after polymerization 
Based on measurements as depicted in Figure 4.2, when comparing the 1000 cm-1 
(benzene ring vibration(181)) Raman band intensity of phenyl disulfide added to 
samples containing varying dilutions of AuNP-PHA synthase and AuNP-coated PHB 
granules based on the OD520 of the samples, the average relative enhancement factor 
for AuNP-coated PHB ranged from 3 ± 0.2 to 11 ± 0.81 across the dilutions tested 
with the highest enhancement observed at the dilution when AuNP-PHA synthase 
reached the limit of detection.  
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4.4.3. Fluorescence Enhancement 
When comparing AuNP-coated and uncoated Nile red-stained PHB granules, 
coated granules exhibited increased fluorescence intensity per unit area of the imaged 
granules with an average enhancement factor of 6.01 ± 1.47.  A concern during these 
measurements was that a larger granule size would contribute to the appearance of 
fluorescence enhancement simply due to a larger Nile red loading capacity.  In fact, 
plotting the fluorescent spot intensity vs. size of fluorescently imaged granules reveals 
a linear increase in fluorescence intensity with increasing unit area.  Nevertheless, 
enhancement in fluorescence intensity comparing nanoparticle-coated and uncoated 
granules is evident (Figure 4.4). 
To examine the photobleaching characteristics of coated and uncoated Nile red 
granules, the same individual fluorescent spots analyzed for fluorescence enhancement 
were tracked and analyzed for fluorescence intensity per unit area in subsequent image 
sequences taken during continuous illumination by the microscope excitation source.  
Indeed, an increase in photo stability of Nile red was observed (Figure 4.5) with a 1.3 
± 0.21-fold decrease in the fluorescence intensity decay rate for Au-coated PHB (0.16 
± 0.030 s-1) compared to PHB alone (0.20 ± 0.015 s-1).  In addition, based on fitting of 
the photo bleaching data, once bleaching has reached steady-state, AuNP-coated PHB 
granules would remain 4.73 ± 1.11-times more intense than PHB granules alone.    
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Figure 4.4: Enhanced fluorescence from stained AuNP-coated PHB granules 
The fluorescence intensity of Nile red-stained PHB granules (black) and Nile red-
stained AuNP-coated PHB granules (red) was plotted vs. granule size ad determined 
from fluorescence microscopy.  A linear increase in fluorescence intensity with 
increasing granule unit area was observed for both samples in addition to a 
fluorescence intensity per unit area enhancement factor of 6.01 ± 1.47 when 
comparing AuNP-coated and uncoated Nile red-stained PHB granules.  
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Figure 4.5: Increased photo stability of stained AuNP-coated PHB granules 
The individual fluorescent PHB granules (black) and AuNP-coated PHB granules 
(red) were analyzed for fluorescence intensity through image sequences taken during 
continuous illumination by the fluorescence microscope.  The plot shows second order 
exponential decay fits (R2 > 0.99) of the average intensity per unit area vs. time for 
each sample.  When comparing the rate constants of the fitted data, a 1.3 ± 0.21-fold 
decrease in the fluorescence intensity decay rate was observed for Au-coated PHB 
(0.16 ± 0.030 s-1) compared to PHB alone (0.20 ± 0.015 s-1).  In addition, AuNP-
coated PHB granules remained 4.73 ± 1.11-times more intense than PHB granules 
alone at steady state.  
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The AuNP particle coating and their arrangement on the PHB granule surface 
reveal the likely source of fluorescent enhancement.  Figure 4.6 depicts the possible 
AuNP-coated PHB granule geometry with regard to SERS and enhanced fluorescence.  
In the diagram, yellow stars represent Nile red that is shown to be incorporated in the 
hydrophobic PHB core as well as the hydrophobic layer comprised of the interface 
between the phospholipid tails of PL-PEG and oleic acid/oleylamine surrounding the 
AuNP.  The blue stars represent a Raman reporter molecule that similarly can become 
incorporated in these hydrophobic regions and which can also bind to the gold 
nanoparticle surface via its disulfide group(180).  When a fluorophore is localized to 
metal particles or surfaces at less than ~5 nm, its emission is quenched by energy 
transfer to the metal(82).  However, at further distances from the metal (between 5 and 
70 nm), increases in fluorescence can be observed(82-85).  While Nile red stains the 
PHB granule, it may also stain the hydrophobic layer around the AuNPs formed by the 
oleic acid/oleylamine and phospholipid tails surrounding the particles.  This layer, 
however, is less than 5 nm thick given our DLS particle size data and judging by the 
molecular dimensions of oleic acid, oleylamine, and the phospholipid (Figure 2.5).  
We have observed that Nile red within this layer is quenched by the gold nanoparticles 
(Figure 4.7)(82).  Quenching is expected due to the proximity of Nile red to the gold 
nanoparticle surface and since there is appreciable overlap between the extinction of 
the gold particles and the Nile red fluorescence spectrum(183).  Conversely, given 
DLS measurements and the molecular dimensions of the nanoparticle coating (Figure 
2.7), Nile red absorbed within the PHB granule is at a distance of at most ~25 nm to 
the gold particle (Figure 4.6).  Fluorescence enhancement has been observed between 
5 nm and 70 nm away from nanostructured metallic surfaces, thus due to the 
configuration of AuNP-coated PHB granules, Nile red within the PHB granule is 
within a distance where enhanced fluorescence is possible(183). 
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  Since Nile red was always included in excess in these experiments, another 
possibility that could explain the observed phenomenon may be instead that stained 
native PHB granules actually exhibit less than optimal fluorescence due to auto-
quenching of excess Nile red or high labeling density and that a fundamental 
difference in PHB core structure of AuNP-coated PHB could have resulted the 
incorporation of relatively less Nile red or lower labeling density in these structures 
leading to less auto-quenching.  Nevertheless, this scenario does not take into account 
the observed decrease in photobleaching in samples containing AuNP-coated PHB 
granules since a less degree of photobleaching would be expected from quenched 
molecules.    
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Figure 4.6: AuNP-coated PHB granule structure 
The figure depicts the possible AuNP-coated PHB granule geometry with regard to 
SERS and enhanced fluorescence.  Yellow stars represent Nile red that is shown 
incorporated in the hydrophobic PHB core as well as the hydrophobic layer 
comprised of the interface between the phospholipid tails of PL-PEG and oleic 
acid/oleylamine surrounding the AuNP.  The blue stars represent a Raman reporter 
molecule that similarly can become incorporated in these hydrophobic regions and 
which can also bind to the gold nanoparticle surface via its disulfide group.  
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Figure 4.7: AuNP-PHA synthase and AuNP-PHB absorption spectra and Nile red 
quenching 
The figure shows absorption spectra of AuNP-PHA synthase and AuNP-coated PHB 
superimposed on the emission spectra of Nile red fluorescence and quenched Nile red 
fluorescence due to the addition of AuNP-PHA synthase.  Due to the aggregation of 
the gold nanoparticles on the PHB granule surface, broadening in the plasmon 
resonance of the AuNP-coated PHB granules over AuNP-PHA synthase was observed. 
When AuNP-PHA synthase conjugates are added to solutions containing PL-PEG-
COOH and Nile red, quenching is observed.  Quenching is likely due to Nile red 
staining of the hydrophobic region formed by the interface between oleic 
acid/oleylamine and phospholipid tails surrounding gold nanoparticles; at this 
location, Nile red is within 5 nm of the gold nanoparticle surface where its emission 
may be quenched by the particle.  
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Furthermore, two phenomena can contribute to fluorescent enhancement 
including surface enhanced fluorescence (SEF) in which the metal particles 
concentrate the local excitation intensity and metal enhanced fluorescence (MEF) in 
which the electric field felt by a fluorophore is affected by interaction of the 
fluorophore oscillating dipole with the metal surface(85-88).  In MEF, an increase in 
the radiative rate is expected, resulting in an increased intensity and decrease in 
photobleaching since the fluorophore spends less time in the excited state for each 
excitation.  Our observation of increased photo stability points to the possibility that 
the nanoparticle coating causes a decrease in the radiative decay rate of the Nile red, 
indicating that MEF contributes to fluorescence enhancement in the system. 
4.4.4. NIR Heating 
NIR-induced heating of AuNP-PHA synthase and AuNP-coated PHB granules 
resulted in a linear temperature increase for each sample with all measurements 
exhibiting an R2 value greater than 0.997 for linear fits of the data.  The 808 nm NIR 
laser illumination of AuNP-coated PHB granules resulted in a 3.9 ± 0.69 increase in 
the heating rate when compared to AuNP-PHA synthase prior to polymerization 
(Figure 4.8), as determined from the slopes of the fitted temperature vs. time plots.  
Due to the aggregation of the gold nanoparticles on the PHB granule surface, 
broadening in the plasmon resonance of the AuNP-coated PHB granules over AuNP-
PHA synthase was observed (Figure 4.7) and the increase in heating rate is likely due 
to increased overlap between the 808 nm laser source and the plasmon of the AuNP-
coated PHB granules(184, 185).  
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Figure 4.8: Enhanced NIR heating of AuNP-coated PHB granules 
Samples of AuNP-PHA synthase conjugates and AuNP-coated PHB granules each 
containing equivalent amounts of AuNP based on their optical density at 520 nm were 
irradiated with an 808 nm NIR laser and while monitoring the temperature of each 
sample.  The temperature of each sample increased linearly over irradiation time and 
the slope of linear fits of the data was used to determine the heating rate for each 
sample.  The figure shows the average heating rate and standard deviation of AuNP-
PHA synthase vs. AuNP-coated PHB upon NIR illumination.  Irradiation of AuNP-
coated PHB granules with 808 nm NIR laser illumination resulted in a 3.9 ± 0.69 
increase in the heating rate when compared to irradiation of AuNP-PHA synthase 
prior to polymerization.  
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4.4.5. Laser-triggered AuNP-PHB-based drug delivery 
Upon loading of Dox to AuNP-coated PHB, the fluorescence intensity of Dox 
increased 5.03 ± 0.248 units over background (Figure 4.9).  This increase is consistent 
with the observed AuNP-induced fluorescence enhancement of Nile red loaded PHB 
granules.  After NIR irradiation, the fluorescence intensity of the sample then dropped 
to an average of 1.99 ± 0.433 units over background levels and the fluorescence 
intensity did not reappear after subsequent measurements of the same sample 10 
minutes and 12 hours after irradiation.  Fluorescence microscopy of Dox-loaded 
AuNP-coated PHB samples before and after irradiation show a decrease in fluorescent 
granules after irradiation (Figure 4.10).  Control experiments confirmed that an 
increase in fluorescence intensity is only observed upon the addition of Dox to AuNP-
coated PHB and not AuNP-PHA synthase indicating that enhancement is caused by 
Dox loading into coated PHB and not simply due to AuNP alone.  Further control 
experiments showed that laser-induced loss of fluorescence intensity was only 
observed in Dox-loaded AuNP-PHB samples and not for Dox-loaded PHB alone or 
AuNP-PHA synthase samples including Dox.   
It is thought that the loss in fluorescence of Dox-loaded AuNP-PHB granules 
is due to destruction of the PHB granule due to local heating of its AuNP coating upon 
laser irradiation.  The decrease in fluorescent granules after laser irradiation observed 
through fluorescence microscopy indicates a loss in granule structure.  This is 
supported by the observation that the loss in fluorescence was not regained after 
prolonged incubation of the sample.  In these samples, the Dox concentration was in 
excess with respect to granule loading capacity and the loss in fluorescence intensity 
would have been expected to be regained in the case that Dox was released while the 
granule remained intact. 
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Figure 4.9: NIR illumination-triggered Dox release from AuNP-coated PHB 
granules 
Dox was added to samples of AuNP-PHA synthase conjugates and AuNP-coated PHB.  
The figure shows the Dox fluorescence intensity in various samples relative to 
background fluorescence exhibited from samples containing Dox and AuNP-PHA 
synthase.  Samples containing AuNP-coated PHB exhibited fluorescence at 5.0 ± 0.25 
units over background due to the loading of Dox into PHB granules and as a result of 
enhanced fluorescence via AuNP-coating on the granules.  Samples where then 
irradiated with an 808 nm NIR laser and their fluorescence was monitored.  
Measurements were taken prior to NIR laser illumination (green) and immediately 
after NIR laser illumination (red) as well as 10 min (orange) and 12 hr (blue) after 
laser irradiation.  After NIR irradiation, the fluorescence intensity of the samples 
dropped to an average of ~2 units over background and the fluorescence intensity did 
not reappear after subsequent measurements of the same sample 10 minutes and 12 
hours after irradiation.  The loss of fluorescence intensity after NIR laser irradiation 
may be due to the destruction of AuNP-coated PHB granules.  
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Figure 4.10: Fluorescence image of Dox-loaded AuNP-coated PHB granules 
before and after NIR laser illumination 
Dox-loaded AuNP-PHB granules were imaged at 100x magnification via fluorescence 
microscopy before (A) and after (B) NIR laser illumination revealing a decrease in 
fluorescent granules after irradiation possibly due to the destruction of AuNP-coated 
PHB granules.  
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4.5. Conclusions 
When compared to AuNP-PHA synthase conjugates, AuNP-coated PHB 
granules exhibited enhancement in SERS properties as well as increased heating rate 
upon NIR illumination.  Nile red-stained AuNP-coated PHB granules also exhibited 
enhanced fluorescence and decreased photobleaching when compared to uncoated 
PHB granules.  NIR irradiation of Dox-loaded PHB granules resulted in loss of Dox 
fluorescence due to destruction of PHB granules providing a potential means of 
triggered drug release from AuNP-PHB granules.  Given the advances in utilizing 
PHB as a matrix for drug-delivery, our AuNP-PHA synthase conjugates may serve as 
multimodal imaging/drug delivery vehicles in which gold nanoparticle-coated PHB 
granules carrying a drug and/or fluorophore may be tracked via fluorescence or SERS 
and may be heated via NIR illumination(52, 178, 179, 186, 187). 
Multimodal particles exhibiting various imaging and therapeutic characteristics 
are emerging as promising platforms in biomedical applications.  In particular, the 
applicability of dual SERS/MEF particles in multiplexed immunoassays was recently 
shown(188).  Furthermore, several studies have demonstrated the utility of gold 
nanoparticle-based SERS imaging in vivo, highlighting the advantages of high signal 
strength as well as the use of these materials as dual imaging and photothermal 
agents(162, 186, 187, 189-191).  In comparison to previously described dual 
SERS/MEF particles that were constructed via layer-by-layer deposition of 
polyelectrolyte coatings on silica cores, AuNP-coated PHB offer a facile self-assembly 
approach for particle formation(188).  Furthermore, the PEGylated AuNP coating 
around PHB granules may facilitate their application in vivo when compared to 
currently employed gold-nanoparticle based theranostic agents among which 100 nm 
gold nanoshells with silica cores are the best studied and are currently undergoing 
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clinical trials(172-174, 186).  Upon their systemic administration, these nanoshells are 
cleared from the blood stream within 24 hours and accumulate in the liver and spleen 
where they are retained by the body for months(186).  The retention of the nanoshells 
is likely due to their opsonization by serum proteins and subsequent uptake by the 
RES where they are retained within Kupffer cells(146).  The Kupffer cells eventually 
can begin to eliminate the nanoparticles via cell turnover – a process that may take up 
to six months resulting long-term nanoparticle retention in the body(192).  In contrast 
to these nanoshells, AuNP-coated PHB granules may result in an alternate clearance 
pathway from their potential for decreased opsonization due to the densely-packed 
PEG coating on the AuNP that cover the PHB granule(144, 145).  As a result, AuNP-
coated PHB would instead be cleared via hepatocytes that excrete nanoparticles into 
the bile resulting in the elimination of nanoparticles from the body in weeks rather 
than months(146).  
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Chapter 5 – Conclusions and future directions  
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5.1.  Future studies 
Future studies should move towards demonstrating diagnostic and therapeutic 
applications of AuNP- and SPION-coated PHB including the investigation of the 
biodistribution, cytotoxicity and biocompatibility of the materials.  Due to the 
biocompatible nature of each of the major components that make up our nanoparticle-
coated granules (AuNP, SPION, PEG, and PHB), the nanoparticle-coated granules are 
expected to exhibit low toxicity in cell culture and in vivo applications.  Furthermore, 
the densely-packed nature of PEG coating the nanoparticles that cover the PHB 
granules may improve the biodistribution and clearance of nanoparticle-coated 
granules when compared to PEGylated particles of similar size to the PHB granules.   
Some of the unique advantages of PHB-based nanoparticles for biomedical 
applications are derived from the biodegradability and biocompatibility of the 
biopolymer in combination with their biosynthetic means of production.  PHB 
implants have been shown to degrade over periods greater than 1 year(193-195).  
When prolonged stability is desired, this offers a potential advantage over other 
available biodegradable polymers such as poly(lactic acid) or poly(glycolic acid) 
which degrade in vivo over a period of 1-2 months(27).  Nevertheless, in cases where 
prolonged stability is not desired, the degradation rate of the polymer can be increased 
via modification of the chemical composition of PHB through the selection of 
monomers that render the polymer more susceptible to hydrolysis or enzymatic attack.  
Monomers that have been used for this purpose include glycolic acid, lactic acid, and 
2-hydroxyethoxy acetic acid which modulate the reactivity of the ester linkage(195).  
In this manner, the in vivo degradation of PHB-based materials has been reduced to 
months(195).  In addition, biosynthetic production of PHB granules has been 
highlighted as a means of avoiding the use of organic solvents in particle 
 98 
production(27, 63), nevertheless, since PHA synthase is derived from bacterial 
sources, the need for pyrogen removal is an unexplored concern(15). 
5.2.  Conclusions 
PHB is proving to be a promising class of biodegradable and biocompatible 
polymer for biomedical applications.  The recent recognition of PHB granules as 
nanoparticles(15, 196) that can be functionalized to suit various applications is 
resulting in exciting diagnostic and therapeutic studies that employ PHB granules.   
The studies in this dissertation describe a novel means of producing 
nanoparticle-coated PHB granules that expands the capabilities of functionalized PHB 
granules through harnessing versatile properties of inorganic nanoparticles.  The 
properties of AuNP- and SPION-coated PHB granules outlined in Chapters 3 and 4 
show that the materials are promising candidates for use in various biomedical 
applications.  In general, both of these materials may be suitable as multifunctional 
theranostic agents as summarized in Figures 5.1 and 5.2.  SPION-coated PHB granules 
exhibit enhanced MRI contrast and can be loaded with fluorescent dyes and/or drugs.  
These particles are thus multifunctional theranostic agents with imaging (MRI, 
fluorescence) and therapeutic (drug encapsulation) capabilities.  Upon laser 
illumination, AuNP-coated PHB granules can exhibit enhanced SERS and 
fluorescence in addition to heating and drug release.  These particles are thus 
multifunctional theranostic agents with imaging (SERS, fluorescence) and therapeutic 
(heat, triggered drug release) capabilities. 
In conclusion, the work outlined in this thesis offers a novel means of PHB 
granule decoration with inorganic nanoparticles expanding the capabilities of 
functionalized PHB granules through harnessing versatile properties of provided by 
inorganic nanoparticles.  
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Figure 5.1: Multifunctional properties of SPION-coated PHB granules 
SPION-coated PHB granules exhibit enhanced MRI contrast (MRI is denoted by ∇B) 
and can be loaded with fluorescent dyes and/or drugs.  These particles are thus 
multifunctional theranostic agents with imaging (MRI, fluorescence) and therapeutic 
(drug encapsulation) capabilities.  
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Figure 5.2: Multifunctional properties of AuNP-coated PHB granules 
Upon laser illumination, AuNP-coated PHB granules can exhibit enhanced SERS and 
fluorescence in addition to heating and drug release.  These particles are thus 
multifunctional theranostic agents with imaging (SERS, fluorescence) and therapeutic 
(heat, triggered drug release) capabilities.  
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